WO2019220697A1 - Selectively permeable film for application to living body, percutaneous absorption kit, and aesthetic method - Google Patents
Selectively permeable film for application to living body, percutaneous absorption kit, and aesthetic method Download PDFInfo
- Publication number
- WO2019220697A1 WO2019220697A1 PCT/JP2019/004361 JP2019004361W WO2019220697A1 WO 2019220697 A1 WO2019220697 A1 WO 2019220697A1 JP 2019004361 W JP2019004361 W JP 2019004361W WO 2019220697 A1 WO2019220697 A1 WO 2019220697A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cellulose
- permselective membrane
- skin
- membrane
- film
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/20—Applying electric currents by contact electrodes continuous direct currents
- A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
Definitions
- the present disclosure relates to a permselective membrane for biological application, a transdermal absorption kit, and a cosmetic method.
- Patent Document 1 proposes a multilayer technical composite including a layer of a semipermeable membrane having air permeability without releasing an active ingredient to the outside.
- Patent Document 2 proposes a self-supporting cosmetic sheet for skin that can adhere to the skin without a 30-1000 nm adhesive containing a biocompatible hydrophobic polymer layer.
- the present disclosure provides a permselective membrane for bioadhesion, a percutaneous absorption kit, and a cosmetic method that selectively permeate water quickly.
- the permselective membrane for bioadhesion of the present disclosure is a self-supportable permselective membrane for bioadhesion, includes regenerated cellulose, has a thickness of 20 nm to 1300 nm, and selectively permeates water.
- a self-supporting cellulose membrane that selectively permeates water is provided.
- FIG. 1 is a diagram showing an example of an X-ray diffraction pattern of natural cellulose.
- FIG. 2 is an exploded perspective view showing an example of the configuration of the electrode used in the electroporation apparatus.
- FIG. 3A is a diagram illustrating one step of the cosmetic method.
- FIG. 3B is a diagram illustrating one step of the cosmetic method.
- FIG. 3C is a diagram illustrating one step of the cosmetic method.
- FIG. 4 is a schematic perspective view showing a laminated sheet 100 ⁇ / b> B having the cellulose film 100.
- FIG. 5 is a schematic perspective view showing a state where a part of the protective layer 101 is peeled from one main surface of the cellulose film 100.
- FIG. 1 is a diagram showing an example of an X-ray diffraction pattern of natural cellulose.
- FIG. 2 is an exploded perspective view showing an example of the configuration of the electrode used in the electroporation apparatus.
- FIG. 3A is a diagram illustrating one step
- FIG. 6 is a diagram for explaining an example in which the liquid 300 and / or the cream 302 are interposed between the cellulose film 100 and the skin 200.
- FIG. 7 is a view showing a state in which the laminated sheet 100B is stuck on the skin 200.
- FIG. 8 is a diagram showing a state in the middle of peeling off the protective layer 101 from the cellulose film 100 on the skin 200.
- FIG. 9 is a schematic perspective view showing a laminated sheet 100 ⁇ / b> C having the cellulose film 100, the protective layer 101, and the second protective layer 102.
- FIG. 10 is a schematic perspective view showing a state where a part of the protective layer 101 is peeled from the cellulose film 100 of the laminated sheet 100C.
- FIG. 11 is a view showing a state in which a laminated sheet of the cellulose film 100 and the second protective layer 102 is applied to the skin 200.
- FIG. 12 is a diagram schematically illustrating a state in which the colored cellulose film 100b is attached to the skin 200.
- FIG. 13 is a diagram showing the penetration of hyaluronic acid (Mw: 2000-4000) into skin in Example 1 and Comparative Example 1-6.
- FIG. 14 is a graph showing the penetration of hyaluronic acid (Mw: 5000-10000) into skin in Example 1 and Comparative Example 1-2.
- FIG. 15 is a diagram showing the penetration of vitamin C into skin in Example 1 and Comparative Example 1.
- FIG. 16 shows the results of Examples 1 and 3 and Comparative Examples 4 and 8 and shows the relationship between the thickness of the regenerated cellulose and the adhesion to the skin.
- Conventional sheet packs for retaining active ingredients on the skin may have air permeability, that is, water vapor permeability, in order to suppress the stuffiness of the skin.
- conventional sheet packs cannot selectively permeate liquid water.
- the present inventor has conceived that a membrane containing regenerated cellulose is used for percutaneous absorption, and in the process of studying the structure of regenerated cellulose, the membrane containing regenerated cellulose quickly permeates liquid water. Found to get.
- an aqueous solution containing an active ingredient such as beauty can be concentrated and held on the skin, and the cosmetic ingredient can be absorbed more efficiently from the skin.
- the inventor of the present application has come up with a novel permselective membrane for living body application, a transdermal absorption kit, and a cosmetic method.
- the outlines of the permselective membrane for living body application, the transdermal absorption kit and the cosmetic method of the present disclosure are as follows.
- a self-supporting permselective membrane for bioadhesion which comprises regenerated cellulose, has a thickness of 20 nm to 1300 nm, and selectively permeates water.
- Item 11 The cosmetic method according to Item 10, wherein the infiltrating step uses at least one selected from the group consisting of a perforation forming method, an ion introduction method, and an ultrasonic introduction method.
- the permselective membrane for biological application includes regenerated cellulose and has a thickness of 20 nm to 1300 nm. Moreover, the permselective membrane for biological sticking can selectively permeate
- Regenerated cellulose is, for example, cellulose substantially represented by the following formula (I).
- the cellulose substantially represented by the formula (I) means a cellulose in which 90% or more of hydroxyl groups of glucose residues in the cellulose represented by the formula (I) remain.
- the ratio of the hydroxyl group in glucose of cellulose can be quantified by a known method such as X-ray photoelectron spectroscopy (XPS).
- XPS X-ray photoelectron spectroscopy
- said definition means that the cellulose may contain the branched structure.
- the artificially derivatized cellulose typically does not fall under “substantially the cellulose represented by the formula (I)”.
- “cellulose substantially represented by the formula (I)” does not exclude cellulose regenerated through derivatization. Even cellulose regenerated through derivatization may fall under “substantially represented by formula (I)”.
- Regenerated cellulose may be uncrosslinked.
- regenerated cellulose means cellulose that does not have the crystal structure I unique to natural cellulose.
- the crystal structure of cellulose can be confirmed by an X-ray diffraction pattern.
- FIG. 1 shows an example of an X-ray diffraction pattern (CuK ⁇ ray (50 kV, 300 mA)) of natural cellulose.
- X-ray diffraction pattern shown in FIG. 1 peaks around 14-17 ° and 23 °, which are peculiar to the crystal structure I, appear.
- Regenerated cellulose often has a crystalline structure II and has peaks around 12 °, 20 ° and 22 °, and no peaks around 14-17 ° and 23 °.
- the raw material of regenerated cellulose is not particularly limited.
- the raw material of the regenerated cellulose can be plant-derived natural cellulose, bio-derived natural cellulose, regenerated cellulose such as cellophane, or processed cellulose such as cellulose nanofiber. It is advantageous that the concentration of impurities in the raw material of regenerated cellulose is 10% by weight or less.
- Cellulose has excellent biocompatibility and is hydrophilic but not soluble in water.
- the regenerated cellulose can form a strong film even if it is thin because hydrogen bonds are uniformly formed in units smaller than the nanofibers of natural cellulose.
- it has a hydroxyl group capable of interacting with a large amount of water in the molecule, so it is considered that water can easily be selectively passed.
- being excellent in biocompatibility or having biocompatibility means that it is difficult to cause reactions such as rashes and inflammations on the living body, particularly the skin.
- the permselective membrane for bioadhesion has a thickness of 20 nm or more and 1300 nm or less.
- the permselective membrane for bioadhesion can be self-supporting.
- the permselective membrane for bioadhesion has a thickness of 1300 nm or less, it can follow the expansion and contraction of the skin surface and can be applied to the skin for a long time without using an adhesive or the like.
- a thickness of 1300 nm or less it becomes possible to quickly permeate water quickly.
- the thickness of the permselective membrane for bioadhesion may have a thickness of 50 nm to 1000 nm. When the thickness is 50 nm or more, higher strength is obtained, and handling of the permselective membrane for attaching a living body becomes easier. When the thickness of the permselective membrane for biological application is 1000 nm or less, the cellulose membrane 100 is inconspicuous when applied to the skin, which is beneficial.
- the permselective membrane for living body sticking may have a thickness of 500 nm or more and 1000 nm or less. When the thickness is 500 nm or more, a permselective membrane for attaching a living body that has higher strength and is difficult to break can be obtained.
- the permselective membrane for living body sticking may have a thickness of 100 nm to 500 nm. When the thickness is 100 nm or more, it is advantageous for maintaining the shape of the thin film. By setting the thickness to 500 nm or less, the adhesiveness of the permselective membrane for biological application can be further improved. Therefore, the permselective membrane for biological application can be applied to the skin or other surface for a longer time and stably. Moreover, since the permselective membrane for bioadhesion becomes thinner, the permselective membrane for bioadhesion can be made inconspicuous on the skin.
- the thickness of the permselective membrane for bioadhesion is determined by, for example, measuring the thickness of the permselective membrane for bioadhesion at a plurality of locations and averaging.
- the thickness at each location can be measured using, for example, a stylus profiling system DEKTAK (registered trademark) manufactured by Bruker Nano Inc.
- self-supportable means that the form as a film can be maintained without a support. For example, when a part of the film is picked up by using fingers, tweezers or the like and the film is lifted, the whole film can be lifted without a support without damaging the film.
- the permselective membrane for bioadhesion contains regenerated cellulose
- the pores derived from the structure of the regenerated cellulose and the hydroxyl group of glucose, which is a repeating unit of the regenerated cellulose are rapidly transferred to the permselective membrane for bioadhesive. And gives selective permeability.
- selectively transmitting water means that liquid water is transmitted and molecules and ions larger than water are difficult to be transmitted, that is, substantially not permeated.
- Molecules and ions larger than water have a molecular weight of, for example, about 60 or more.
- the permselective membrane for biological application selectively permeates water. It is defined as substantially not transmitting molecules and ions having a molecular weight of 60 or more. More preferably, the concentration of the active ingredient in the permeated water is 1/20 or less, more preferably less than the detection limit.
- Examples of the method for detecting the active ingredient include mass spectrometry, analysis using an absorptiometer, and analysis using a fluorescence microscope when the active ingredient is a phosphor.
- the permeation rate of water depends on the thickness of the permselective membrane for biological application.
- the permselective membrane for bioadhesion has a thickness of 20 nm or more and 1300 nm or less, discoloration of the paper disposed below can be confirmed by the above-described method within approximately 30 seconds.
- to selectively permeate water quickly confirms that liquid water has permeated from one surface of the selective permeation membrane for living body application to the other surface by visual observation within several tens of seconds. It means that water permeates as fast as possible.
- the regenerated cellulose contained in the permselective membrane for biological application has a weight average molecular weight of 150,000 or more.
- a weight average molecular weight of 150,000 or more more hydroxyl groups are included per molecular chain, and more hydrogen bonds between molecules are formed, so that the thickness is 20 nm or more and 1300 nm or less.
- a membrane capable of maintaining the shape without requiring a support can be obtained.
- the permselective membrane for biological application only needs to contain a regenerated cell roll, and may contain inevitable impurities, raw materials, other additive materials, and the like.
- the permselective membrane for bioadhesion contains regenerated cellulose at a ratio of 90% by mass or more.
- the regenerated cellulose contained in the permselective membrane for biological application may have a crystallinity of 0 to 12%. According to an exemplary production method described later, it is possible to obtain a cellulose film having a crystallinity of 0%. When the degree of crystallinity is 12% or less, the adhesion of the cellulose film to the skin can be improved by appropriately reducing the proportion of hydroxyl groups involved in the formation of crystal forms. Furthermore, since the amount of hydroxyl groups involved in the formation of the crystal structure is moderately small, the number of hydroxyl groups that interact with water increases, and water can be selectively permeated more quickly. In addition, by performing a predetermined chemical modification at a site where a hydroxyl group should exist, the permselective membrane for biological application can exhibit various functions.
- the permselective membrane for biological application has a water absorption of 50% or more.
- the water absorption rate is defined by the same method as described in JIS K7209.
- the water absorption is more preferably 100% or more.
- the thickness of the membrane is 20 nm or more and 1300 nm or less and the electrical resistance is low, there is little voltage drop due to the resistance of the permselective membrane for living body application, and an iontophoresis device, an electroporation device, and an ultrasound introduction device are used.
- an aqueous solution containing an active ingredient is disposed between the skin and the permselective membrane for attaching to a living body, the effect of introducing the active ingredient into the skin by these devices can be further enhanced.
- the permselective membrane for biological application preferably has a pore volume of 0.3 cm 3 / g or less.
- the permselective membrane for biological application can exhibit high water selective permeability.
- the permselective membrane for biological application can exhibit higher water permselectivity.
- the pore volume in the present specification means the volume of pores having a pore diameter of 100 nm or less.
- the pore volume can be determined by, for example, a gas adsorption method.
- the permselective membrane for biological application has high transparency, it is considered that there are almost no pores larger than 100 nm.
- the permselective membrane for biological application has a pore volume of, for example, 0.001 cm 3 / g or more.
- the membrane for living body application of this embodiment, having a thickness of 20 nm or more and 1300 nm or less, the membrane can be made into a living body only with skin lotion or cosmetic liquid without the adhesive that caused the rash. It can be applied for a long time.
- the main component of the permselective membrane for bioadhesion is regenerated cellulose, it is excellent in biocompatibility and can be used for a long time without any burden on the living body.
- the permselective membrane for living body application can selectively permeate water
- an aqueous solution containing an active ingredient for medical or cosmetic use is placed between the living body and the permselective membrane for attaching living body.
- a certain water selectively permeates through the permselective membrane for bioadhesion and floats on the surface of the permselective membrane for bioadhesion. For this reason, when the solvent of the aqueous solution in contact with the living body is reduced, the concentration of the active ingredient is increased, and the concentration of the active ingredient is increased due to the concentration gradient.
- Regenerated cellulose can easily form hydrogen bonds within the molecule and / or between the molecules, has a high strength even if it is thin, and can obtain an appropriate flexibility and a film that is not easily broken.
- active ingredients such as cosmetic ingredients can be carried in the film. Since regenerated cellulose exhibits amphiphilic properties, it can appropriately carry a hydrophilic active ingredient and a hydrophobic active ingredient.
- the active ingredient is not limited to a cosmetic ingredient but may be a medical ingredient.
- the permselective membrane for bioadhesion according to an embodiment of the present disclosure can be used by being affixed to skin such as a face or an arm.
- the permselective membrane for biological application according to an embodiment of the present disclosure typically has an area of 7 mm 2 or more. When the area of the cellulose membrane is 7 mm 2 or more, it is beneficial because it covers a larger area when applied to the skin.
- the permselective membrane for bioadhesion of the present disclosure can be applied to a living body other than skin, and may be applied to the surface of an organ, for example.
- the permselective membrane for biological application has a tensile strength of 23 MPa or more, for example.
- the permselective membrane for living body application is not easily broken even if it is applied to the skin, and can be applied to the skin for a long time.
- the permselective membrane for bioadhesion of the present disclosure may be at least partially colored.
- the permselective membrane for biological application can be produced, for example, by the following method. First, cellulose is dissolved in a solvent to prepare a cellulose solution. In order to obtain a regenerated cellulose membrane having a weight average molecular weight of 150,000 or more, a cellulose solution may be prepared using cellulose having a weight average molecular weight of at least 150,000 or more. In this case, a self-supporting permselective membrane for attaching a living body having a thickness of 1300 nm or less can be produced.
- the weight average molecular weight of cellulose used in the preparation of the cellulose solution is 150,000 or more, more intermolecular hydrogen bonds are formed by including more hydroxyl groups in one molecular chain. Therefore, it is possible to stably produce a permselective membrane for bioadhesion of 1300 nm or less.
- the cellulose used for preparing the cellulose solution is not particularly limited as long as it has a desired weight average molecular weight.
- cellulose used for preparing the solution any of natural cellulose and regenerated cellulose can be used.
- Cellulose can be, for example, cellulose derived from plants such as pulp and cotton, or cellulose produced by organisms such as bacteria.
- the impurity concentration in the cellulose raw material is, for example, 10% by weight or less.
- the weight average molecular weight of regenerated cellulose is 2, Since it is easy to handle when it is 000,000 or less, it is useful. More desirably, the regenerated cellulose has a weight average molecular weight of 1,000,000 or less.
- the solvent is, for example, a solvent (first solvent) containing at least an ionic liquid.
- An ionic liquid is a salt composed of an anion and a cation, and can exhibit a liquid state at a temperature of 150 ° C. or lower.
- the ionic liquid contained in the first solvent is, for example, an ionic liquid containing an amino acid or an alkyl phosphate ester.
- the first solvent contains such an ionic liquid, cellulose can be dissolved while suppressing a decrease in the molecular weight of cellulose.
- an amino acid is a component that exists in a living body
- an ionic liquid containing the amino acid is advantageous for producing a permselective membrane for biological application that is safer for a living body.
- the cellulose may be dissolved by using an ionic liquid diluted in advance with a solvent that does not precipitate the cellulose.
- an ionic liquid diluted in advance with a solvent that does not precipitate the cellulose.
- a mixture of an aprotic polar solvent and an ionic liquid may be used as the first solvent.
- the aprotic polar solvent hardly forms hydrogen bonds and does not easily precipitate cellulose.
- the ionic liquid contained in the first solvent is, for example, an ionic liquid represented by the following formula (II).
- the anion is an amino acid.
- the anion in this ionic liquid, contains a terminal carboxyl group and a terminal amino group.
- the cation of the ionic liquid represented by the formula (II) may be a quaternary ammonium cation.
- R1 to R6 independently represent a hydrogen atom or a substituent.
- the substituent can be an alkyl group, a hydroxyalkyl group, or a phenyl group.
- the substituent may contain a branch in the carbon chain.
- the substituent may contain a functional group such as an amino group, a hydroxyl group, or a carboxyl group.
- n is, for example, 4 or 5.
- the ionic liquid contained in the first solvent may be an ionic liquid represented by the following formula (III).
- R1, R2, R3 and R4 independently represent a hydrogen atom or an alkyl group having 1 to 4 carbon atoms.
- a second solvent may be further added.
- the second solvent may be further added to a mixture of cellulose having a predetermined weight average molecular weight and the first solvent.
- the second solvent is, for example, a solvent that does not precipitate cellulose.
- the second solvent can be, for example, an aprotic polar solvent.
- the concentration of cellulose in the cellulose solution is typically 0.2 to 15% by weight. If the cellulose concentration of the cellulose solution is 0.2% by weight or more, a biopermeable selective permeable membrane having a strength necessary for maintaining the shape of the biopermeable selective permeable membrane can be obtained while reducing the thickness of the biopermeable selective permeable membrane. . Moreover, if the density
- the cellulose concentration of the cellulose solution may be 1 to 10% by weight. When the concentration of cellulose in the cellulose solution is 1% by weight or more, a permselective membrane for bioadhesion having higher strength can be obtained. When the concentration of cellulose in the cellulose solution is 10% by weight or less, a stable cellulose solution in which precipitation of cellulose is further reduced can be prepared.
- a cellulose solution is applied to the surface of the substrate to form a liquid film on the surface of the substrate.
- substrate is 90 degrees or less, for example.
- the wettability of the cellulose solution to the substrate is appropriate, and a liquid film that spreads along the surface of the substrate can be stably formed.
- the material of the substrate is not particularly limited.
- the substrate typically has a non-porous structure with a smooth surface. In this case, it is possible to prevent the cellulose solution from entering the inside of the substrate, and it is easy to separate the permselective membrane for biological application from the substrate in a subsequent process.
- the substrate may be chemically or physically surface modified.
- a polymer material substrate that has been subjected to surface modification treatment such as ultraviolet (UV) irradiation or corona treatment may be used.
- the method for surface modification is not particularly limited. For example, application of a surface modifier, surface modification, plasma treatment, sputtering, etching, or blasting can be applied.
- a method for forming a liquid film of a cellulose solution on a substrate includes, for example, gap coating, slot die coating, spin coating, coating using a bar coater (Metering) that forms a predetermined gap with the surface of the substrate by an applicator or the like. rod coating) and gravure coating.
- the thickness of the liquid film adjusted by the gap thickness or slot die opening size and coating speed, spin coating speed, bar coater or gravure coating groove depth and coating speed, etc., and the concentration of the cellulose solution. By adjusting, the thickness of the permselective membrane for biological application can be adjusted.
- the method for forming the liquid film of the cellulose solution on the substrate may be a casting method, screen printing using a squeegee, spray coating, or electrostatic spraying.
- At least one of the cellulose solution and the substrate may be heated. This heating may be performed, for example, in a temperature range (for example, 40 to 100 ° C.) in which the cellulose solution can be kept stable.
- the liquid film of the cellulose solution formed on the substrate may be heated.
- the liquid film is heated, for example, at a temperature lower than the decomposition temperature of the ionic liquid contained in the first solvent (for example, 50 to 200 ° C.).
- the heating of the liquid film may be performed at a temperature lower than the decomposition temperature of the ionic liquid and lower than the boiling point of the second solvent.
- the heating of the liquid film may be performed under a reduced pressure environment.
- a solvent other than the ionic liquid can be appropriately removed in a shorter time at a temperature lower than the boiling point of the solvent.
- the liquid film may be gelled.
- the liquid film may be gelled.
- the liquid film by exposing the liquid film to vapor of a liquid that is soluble in an ionic liquid and does not dissolve cellulose, the liquid film can be gelled to obtain a polymer gel sheet.
- the ionic liquid in the liquid film comes into contact with water, so that the solubility of cellulose in the liquid film decreases. Thereby, a part of cellulose molecule precipitates and a three-dimensional structure is formed. As a result, the liquid film is gelled.
- the presence or absence of a gel point can be determined by whether or not the gelled film can be lifted.
- the crystallinity of the cellulose film finally obtained can be adjusted according to the conditions of the gelation process. For example, when gelation is performed in an environment where the relative humidity is 60% RH or less, the gelation gradually proceeds, so that it is easy to stably form a three-dimensional structure of cellulose molecules, and the crystallinity is stably reduced. obtain. In an environment where the relative humidity is 40% RH or less, it is possible to obtain a regenerated cellulose membrane with a further reduced crystallinity.
- the heating of the liquid film may be performed before gelling of the liquid film, may be performed after gelling of the liquid film, or may be performed before or after gelling of the liquid film. .
- the substrate and the polymer gel sheet are immersed in a rinsing liquid that does not dissolve cellulose.
- the ionic liquid is removed from the polymer gel sheet.
- This step is understood as a step of washing the polymer gel sheet.
- a part of the components (for example, the second solvent) other than the cellulose and the ionic liquid may be removed from the components contained in the cellulose solution.
- the rinsing liquid may be replaced a plurality of times.
- the rinse liquid is typically a liquid that can be dissolved in an ionic liquid.
- liquids examples include water, methanol, ethanol, propanol, butanol, octanol, toluene, xylene, acetone, acetonitrile, dimethylacetamide, dimethylformamide, and dimethyl sulfoxide.
- the polymer gel sheet is dried.
- the polymer gel sheet may be dried on a protective layer or the like.
- drying methods such as natural drying, vacuum drying, heat drying, freeze drying, and supercritical drying can be applied.
- the polymer gel sheet may be dried by vacuum heating.
- the conditions for drying the polymer gel sheet are not particularly limited.
- a condition for drying the polymer gel sheet a time and temperature sufficient for removing unnecessary components such as the second solvent and the rinse liquid are selected. By removing unnecessary components from the polymer gel sheet, a regenerated cellulose membrane is obtained.
- the polymer gel sheet may be pulled with a predetermined force.
- the pore volume and shape of the regenerated cellulose membrane, the bulk density of the regenerated cellulose, and the like can be adjusted to a desired state by adjusting the magnitude of the tensile force applied to the polymer gel sheet.
- a solvent that can be frozen and has a boiling point of about 100 to 200 ° C. is used.
- lyophilization can be performed using a solvent such as water, tert-butyl alcohol, acetic acid, 1,1,2,2,3,3,4-heptafluorocyclopentane, or dimethyl sulfoxide.
- the solvent used for lyophilization is advantageously a solvent that can be dissolved in the rinse solution.
- the rinse solution in the polymer gel sheet can be dissolved in the rinse solution after the step of immersing the polymer gel sheet in the rinse solution. It is possible to carry out lyophilization by substituting with a solvent and further substituting the solvent with a solvent for lyophilization.
- the solution may contain a plurality of active ingredients.
- the solvent in the solution for example, at least one selected from the group consisting of water, methanol, ethanol, propanol, butanol, octanol, toluene, xylene, acetone, acetonitrile, dimethylacetamide, dimethylformamide, and dimethylsulfoxide can be used.
- an adhesive component may be attached to the polymer gel sheet by spraying, vapor deposition, or coating.
- an aqueous solution containing an active ingredient is disposed between the above-described permselective membrane for biological application and the skin.
- the aqueous solution may be in the form of a solution, a dispersion, or an emulsion as long as it contains water.
- An active ingredient is an ingredient which shows cosmetic effects such as moisturizing and whitening on the skin.
- plant-derived polymers xanthan gum, dextran, succinoglucan, bullulan and other microorganism-derived polymers, collagen, casein, albumin, gelatin and other animal-derived polymers, hyaluron Biological polymer compounds such as acid, mucin, chondroitin sulfate, soluble collagen, polyethylene glycol, sorbitol, xylitol, maltose, sodium dl-pyrrolidonecarboxylate, sodium lactate, trime Vitamin A such as luglycine, retinol, retinal, retinoic acid,
- aqueous solution containing an active ingredient between the skin and the selective permeable membrane for biological application that selectively permeates water, only water quickly penetrates the selective permeable membrane for biological application and is effective on the skin. Concentrates the ingredients, showing the effect that the active ingredients can easily penetrate from the skin to the inside. That is, the transdermal absorption effect can be enhanced.
- a transcutaneous kit includes the permselective membrane for biological application, and at least one selected from the group consisting of an iontophoresis device, an electroporation device, and an ultrasound introduction device.
- an active ingredient having a molecular weight of 500 or more which is generally considered difficult to penetrate into the skin, can be easily penetrated into the skin.
- FIG. 2 shows an example of the electrode pad 10 used in the electroporation apparatus.
- the electrode pad 10 includes the first electrode 23 and the second electrode 24, the insulating layers 21 a and 21 b disposed on one surface of the first electrode 23 and the second electrode 24, and the first electrode 23 and the second electrode 24. Insulating layers 25a and 25b disposed on the surface. Since the electrode 10 includes the insulating layers 25a and 25b, current can be prevented from flowing into the living body, and treatment can be performed without feeling any damage.
- FIG. 3A to FIG. 3C are views for explaining a cosmetic method using a transdermal absorption kit.
- an aqueous solution 40 containing an active ingredient is applied to the skin 30.
- the selective permeable membrane 100 for attaching a living body is attached to the skin 30 so as to cover the aqueous solution 40.
- the electrode pad 10 is disposed on the permselective membrane 100 for attaching a living body.
- the first electrode 23 and the second electrode 24 of the electrode pad 10 are connected to the electroporation device body 60, and the electroporation device is operated.
- An electric pulse is applied to the skin 30 through the electrode pad 10.
- a minute hole is temporarily formed on the surface of the skin 30, and the active ingredient is infiltrated into the inside through the hole.
- the selective permeable membrane 100 for biological application selectively transmits water in the aqueous solution 40, the active ingredient in the aqueous solution 40 in contact with the skin 30 is concentrated. For this reason, the active ingredient which is in contact with the skin at a high concentration becomes easier to penetrate into the inside by the electroporation method.
- FIG. 3C shows how to use the transdermal kit including the iontophoresis device 70.
- an aqueous solution 40 containing an active ingredient is applied to the surface of the skin 30, and the biopermeable selective permeable membrane 100 is attached to the skin 30 so as to cover the aqueous solution 40.
- the head 70a of the iontophoresis device 70 is brought into contact with the biological attachment selective permeable membrane 100.
- a current path is formed between the user and the iontophoresis device 70 as indicated by a broken line by the user gripping the grip 70b of the iontophoresis device 70 by hand.
- the active ingredient is allowed to penetrate into the living body according to this current path.
- the active ingredient is an ion, and the active ingredient can efficiently penetrate into the skin 30 by appropriately selecting the charge and current direction of the active ingredient.
- the permselective membrane 100 for adhering to the living body selectively permeates the water in the aqueous solution 40, so that the active ingredient in the aqueous solution 40 in contact with the living body 30 is concentrated. For this reason, the active ingredient which is in contact with the skin at a high concentration is more easily penetrated into the inside by the iontophoresis method.
- the iontophoresis device and the electroporation device can be used independently, but may be used in combination. In this case, for example, first, a temporary hole is formed in the skin using an electroporation device, and then an active ingredient can be more efficiently penetrated into the living body from the formed hole by using the iontophoresis device. .
- the ultrasonic introduction device can be used in the same manner as the ion introduction device.
- An ultrasonic introduction device may also be used in combination with an ion introduction device and / or an electroporation device.
- a temporary hole is first formed in the skin using an electroporation device, and then the active ingredient penetrates the living body more efficiently from the formed hole when the ultrasonic introduction device is used. Can be made.
- the electroporation apparatus in which the electrode pad 10 is separated from the main body has been described.
- the electroporation apparatus may be a handy type in which the electrode pad 10 is provided integrally with the main body, or the main body and the main body.
- a connected handy type probe may be provided, and the electrode pad 10 may be provided integrally with the probe.
- the active ingredient can be efficiently infiltrated into the living body similarly by using the portion where the electrode pad 10 is provided on the surface of the permselective membrane 100 for attaching a living body.
- (Laminated sheet) 4 and 5 show an example of a laminated sheet according to an embodiment of the present disclosure.
- the permselective membrane for biological application according to an embodiment of the present disclosure may be provided in the form of a laminated sheet to which a protective layer is attached.
- a laminated sheet 100 ⁇ / b> B illustrated in FIG. 4 includes a cellulose film 100 and a protective layer 101 disposed on one main surface of the cellulose film 100.
- the cellulose membrane 100 the above-described permselective membrane 100A for biological application can be applied, and the cellulose membrane 100 can be, for example, a membrane composed of regenerated cellulose having a weight average molecular weight of 150,000 or more.
- FIGS. 4 and 5 schematically show the laminated sheet 100B to the last, and do not reflect actual dimensions.
- the thicknesses of the cellulose film 100 and the protective layer 101 are exaggerated in FIGS.
- a cellulose film or the like may be illustrated in a size and shape different from the actual one.
- the cellulose membrane 100 has a generally circular shape.
- the diameter of the cellulose membrane 100 shown in FIG. 4 can be about 3 mm, for example.
- the shape of the cellulose membrane 100 is not limited to the example shown in FIG. 4, and may be an ellipse, a polygon, or an indefinite shape.
- the cellulose film 100 and the protective layer 101 may have different sizes.
- the cellulose film 100 has main surfaces Sf and Sb, and here, a protective layer 101 is disposed on the main surface Sb side.
- the protective layer 101 includes, for example, polyethylene, polypropylene, polyethylene terephthalate, nylon, acrylic resin, polycarbonate, polyvinyl chloride, acrylonitrile-butadiene-styrene (ABS) resin, polyurethane, synthetic rubber, cellulose, Teflon (registered trademark), aramid, It is a sheet or non-woven fabric such as polyimide, or a sheet-like metal or glass. Moreover, the chemical or physical surface treatment may be given to the whole or a part of the surface of these sheets or nonwoven fabrics.
- the protective layer 101 is also circular like the cellulose film 100.
- the shapes of the cellulose film 100 and the protective layer 101 do not need to match.
- a plurality of cellulose films 100 may be disposed on a single protective layer 101.
- the protective layer 101 in the laminated sheet 100B is not a support for maintaining the shape of the cellulose film 100.
- the protective layer 101 is configured to be peelable from the main surface Sb of the cellulose film 100.
- the cellulose film 100 has a tensile strength of, for example, 23 MPa or more, and can maintain its shape even when the protective layer 101 is peeled off.
- the above-mentioned laminated sheet 100B is prepared, and as shown in FIG. 6, the main surface Sf on which the protective layer 101 is not disposed among the main surfaces Sf and Sb of the cellulose film 100 is formed on the laminated sheet 1. It is made to oppose the part which wants to stick 00B.
- the main surface Sf of the cellulose film 100 is opposed to the skin 200 (for example, a part of the facial skin).
- the aqueous solution 300 containing the above-mentioned active ingredient is applied on the main surface Sf of the cellulose film 100 or on the skin 200.
- a cream 302 may be arranged.
- the cream 302 contains, for example, oils, fats, alcohols or emulsifiers, and may further contain the above-described active ingredients.
- the laminated sheet 100B is attached to the skin 200 as shown in FIG. 7 by bringing the laminated sheet 100B into contact with the skin 200 with the main surface Sf of the cellulose film 100 facing the skin 200. Further, as shown in FIG. 8, the protective layer 101 is peeled from the main surface Sb of the cellulose film 100. By peeling off the protective layer 101 from the cellulose film 100, the cellulose film 100 can be left on the skin 200.
- FIG. 9 shows another example of a laminated sheet.
- a laminated sheet 100C shown in FIG. 9 has a second protective layer 102 on the main surface of the cellulose membrane 100 opposite to the main surface on which the protective layer 101 is disposed.
- the material constituting the protective layer 102 may be the same as or different from that of the protective layer 101.
- the size of the protective layer 102 may be different from that of the cellulose film 100 or the protective layer 101.
- the protective layer 102 can also be peeled from the cellulose film 100 in the same manner as the protective layer 101. The presence of the protective layer 102 makes it easier to handle the cellulose membrane 100.
- the protective layer 101 is peeled from the cellulose film 100 as shown in FIG. By removing the protective layer 101, the main surface Sb of the cellulose film 100 is exposed. Thereafter, the exposed main surface Sb is opposed to the skin 200. As in the case of the laminated sheet 100B, at this time, the aqueous solution 300 containing the active ingredient is applied on the main surface Sb of the cellulose film 100 or on the skin 200. Furthermore, cream 302 may be applied.
- a laminated sheet of the cellulose film 100 and the second protective layer 102 is applied to the skin 200. Thereafter, the protective layer 102 is peeled from the other main surface of the cellulose film 100, that is, the main surface opposite to the main surface Sb. The cellulose film 100 can be left on the skin 200 by peeling off the protective layer 102.
- FIG. 12 schematically shows a state in which the colored cellulose film 100b is attached to the skin 200.
- the cellulose film 100b may be a film obtained by coloring the above-described cellulose film 100 with a dye, a pigment, or the like. According to the manufacturing method described above, a transparent regenerated cellulose membrane is typically obtained.
- the cellulose membrane 100b colored with a color close to the color of the skin when the part on which the active ingredient is applied is a stain, a mole, a scar or the like of the skin 200, the permselective membrane for bioadhesion is covered and is conspicuous. It is possible to eliminate.
- the permselective membrane for biological application can also function as a protective sheet that protects the skin from external irritation, for example, when applied to a scar. You may give a pattern and a color to the selective permeable membrane for biological sticking by printing etc.
- Example 1 Evaluation of penetration of active ingredients
- Example 2 Preparation of permselective membrane for selective biopermeation
- a regenerated cellulose membrane which is a permselective membrane for biological application, was produced by the following procedure. First, a cellulose derived from bleached pulp made of wood and having a purity of 90% or more was prepared.
- a cellulose solution was prepared by dissolving cellulose derived from bleached pulp in an ionic liquid.
- ionic liquid 1-ethyl-3-methylimidazolium diethyl phosphate (manufactured by Aldrich, purity 98%) was used.
- the cellulose solution was diluted with dimethyl sulfoxide.
- a liquid film was formed on the substrate by applying a gap coating and applying a cellulose solution to the surface of the substrate. At this time, the size of the gap was adjusted aiming at the thickness of the regenerated cellulose film being 1000 nm.
- the liquid film of the cellulose solution was heated at 70 ° C. for 1 hour, and then placed in an environment of 20 ° C. and 40-60% RH to obtain a polymer gel sheet. Thereafter, the ionic liquid was removed from the polymer gel sheet by washing the polymer gel sheet. Thereafter, the polymer gel sheet was dried at a tension of about 0.1 N to obtain a regenerated cellulose film having a thickness of about 930 nm that can stand by itself.
- the regenerated cellulose membrane had a rectangular shape of approximately 5 cm ⁇ 5 cm.
- the thickness of the regenerated cellulose film was measured by averaging several points using Bruker Nano Inc.'s stylus profiling system DEKTAK (registered trademark), and averaging the thickness of the regenerated cellulose film placed on the glass plate. Confirmed by measuring.
- the weight average molecular weight of the cellulose in the regenerated cellulose membrane was measured by GPC (Gel Permeation Chromatography) -MALS (Multi Angle Light Scattering) method.
- GPC Gel Permeation Chromatography
- MALS Multi Angle Light Scattering
- a liquid feeding unit LC-20AD manufactured by Shimadzu Corporation was used.
- a differential refractometer Optilab rEX and a multi-angle light scattering detector DAWN manufactured by Wyatt Technology Corporation were used.
- HELEOS was used.
- the column used was TSKgel ⁇ -M manufactured by Tosoh Corporation, and the solvent used was dimethylacetamide to which 0.1 M lithium chloride was added. Measurement was performed under the conditions of column temperature: 23 ° C. and flow rate: 0.8 mL / min.
- the weight average molecular weight of the regenerated cellulose was about 224,000.
- the pore volume was measured by a gas adsorption method using nitrogen using BELSORP-mini2 (Microtrack Bell Co., Ltd.) and analyzed by the BJH method.
- the pore volume of 100 nm or less was 0.016 cm 3 / g.
- the water absorption of the produced film was 198%.
- a 0.1% by weight aqueous solution of fluorescently labeled hyaluronic acid having a molecular weight of 2000 to 4000 (Fluoresceinamine labeled Sodium Hyaluronate (3K2) manufactured by PG Research Co., Ltd.) was dropped from above the regenerated cellulose membrane placed on the substrate. did. 30 seconds after the dropping, the regenerated cellulose membrane was removed, and it was confirmed whether or not the fluorescent hyaluronic acid was detected with a fluorescence microscope by the presence or absence of discoloration due to permeation of water on the base. A fluorescence microscope manufactured by Keyence Corporation was used as the fluorescence microscope.
- the excitation wavelength was 470 nm, the absorption wavelength was 525 nm, and the exposure time was 1/200 s. Discoloration of the groundwork due to water permeation was confirmed.
- Hyaluronic acid by a fluorescence microscope was below the detection limit, and it was confirmed that the regenerated cellulose membrane permeated only water.
- fluorescently labeled hyaluronic acid having a molecular weight of 5000 to 10000 (Fluoresceinamine labeled Sodium Hyaluronate (U2) manufactured by PG Research Co., Ltd.) was also evaluated. It was confirmed that hyaluronic acid by a fluorescence microscope was below the detection limit and that the regenerated cellulose membrane permeated only water.
- an ascorbic acid aqueous solution was dropped from above the regenerated cellulose membrane placed on the base.
- the selective permeable membrane was removed, the presence or absence of discoloration due to the permeation of water on the base, the base was extracted, and it was confirmed whether ascorbic acid was detected by absorption spectrometry.
- Absorption analysis was performed by Shimadzu UV1600, and the absorption at 266 nm was evaluated using a calibration curve. Although discoloration of the groundwork due to water permeation was confirmed, it was confirmed that ascorbic acid by absorption spectrometry was below the detection limit, and that the regenerated cellulose membrane permeated only water.
- Vitamin C sodium ascorbate
- aqueous solution was dropped on the skin, and then a regenerated cellulose membrane was placed and allowed to stand for 30 minutes. Thereafter, a tape for tape stripping was affixed, and two keratins were removed. The third to twelfth (a total of ten) keratins were peeled off with a tape strip at the same location, and used as a measurement sample.
- 4 mL of water was added and subjected to ultrasonic treatment for 3 minutes, and the extracted liquid was evaluated using an LC-Vp10 high performance liquid chromatograph manufactured by Shimadzu Corporation. The results are shown in FIG.
- Example 2 A regenerated cellulose membrane according to Example 2 was produced in the same manner as in Example 1 except that the condition of gap coating was adjusted aiming at a thickness of 300 nm.
- the thickness of the regenerated cellulose film according to Example 2 was 320 nm.
- the pore volume of 100 nm or less was 0.047 cm 3 / g.
- the thickness and pore volume of the regenerated cellulose membrane according to Example 2 were measured in the same manner as in Example 1.
- the regenerated cellulose membrane according to Example 2 was placed on the base, and from that, fluorescently labeled hyaluronic acid having a molecular weight of 2000-4000 and a molecular weight of 5000-10000 was used as an active ingredient.
- fluorescently labeled hyaluronic acid having a molecular weight of 2000-4000 and a molecular weight of 5000-10000 was used as an active ingredient.
- the contained aqueous solution was dropped and allowed to stand for 30 seconds, discoloration of the foundation due to water permeation was confirmed.
- any hyaluronic acid was below the detection limit, and the regenerated cellulose membrane according to Example 2 permeated only water.
- Comparative Example 1 In the evaluation of the penetration of active ingredients into the skin when using the device, a fluorescently labeled aqueous solution of hyaluronic acid (molecular weight 2000-4000 and molecular weight 5000-10000) was applied on the skin on the inner side of the upper arm, and the film was not attached. Evaluation was performed in the same manner as in Example 1 except that perforation formation was performed. The results are shown in FIG. 13 and FIG.
- Comparative Example 2 A polylactic acid solution was prepared by dissolving polylactic acid having a weight average molecular weight of 250,000 in chloroform. After a polylactic acid solution was applied by spin coating on a substrate on which a polyvinyl alcohol film having a weight average molecular weight of about 500 was previously formed, chloroform as a solvent was vaporized. Thereafter, polyvinyl alcohol was removed by immersion in water, and a polylactic acid film of Comparative Example 2 was produced. The thickness of the obtained polylactic acid film was about 960 nm.
- a polylactic acid film was placed on the ground, and an aqueous solution containing fluorescently labeled hyaluronic acid (molecular weight 2000-4000, molecular weight 5000-10000) was dropped on it and placed for 30 seconds. There wasn't. Also, no hyaluronic acid was detected in the fluorescence microscope.
- fluorescently labeled hyaluronic acid molecular weight 2000-4000, molecular weight 5000-10000
- Example 2 In the evaluation of the penetration of active ingredients into the skin, evaluation was performed in the same manner as in Example 1 except that a polylactic acid membrane was used instead of the permselective membrane. The results are shown in FIG. 13 and FIG.
- PET polyethylene terephthalate
- a PET sheet was placed on the base, and an aqueous solution containing fluorescently labeled hyaluronic acid having a molecular weight of 2000-4000 and a molecular weight of 5000-10000 was dropped from the PET sheet as an active ingredient.
- the base material was not discolored and water penetration could not be confirmed.
- no hyaluronic acid was detected in the fluorescence microscope.
- the water absorption rate of the PET sheet was 0.4%.
- Example 2 In the evaluation of the penetration of the active ingredient into the skin, evaluation was performed in the same manner as in Example 1 except that a PET sheet was used instead of the permselective membrane and fluorescently labeled hyaluronic acid having a molecular weight of 2000 to 4000 was used. The results are shown in FIG.
- Example 4 A commercially available cellophane (regenerated cellulose) having a thickness of about 20 ⁇ m is used.
- the solution was dropped and allowed to stand for 30 seconds, but there was no discoloration of the foundation and water penetration could not be confirmed. Also, no hyaluronic acid was detected in the fluorescence microscope.
- the crystallinity of cellophane was 21%.
- Example 2 In the evaluation of the permeability of the active ingredient, evaluation was carried out in the same manner as in Example 1 except that cellophane was used instead of the permselective membrane and fluorescently labeled hyaluronic acid having a molecular weight of 2000 to 4000 was used. The results are shown in FIG.
- Example 2 In the evaluation of the permeability of the active ingredient, evaluation was performed in the same manner as in Example 1 except that filter paper was used instead of the permselective membrane and fluorescently labeled hyaluronic acid having a molecular weight of 2000 to 4000 was used. The results are shown in FIG.
- Example 2 In the evaluation of the permeability of the active ingredient, evaluation was performed in the same manner as in Example 1 except that a nanofiber sheet was used instead of the permselective membrane and fluorescently labeled hyaluronic acid having a molecular weight of 2000 to 4000 was used. The results are shown in FIG.
- Comparative Example 7 A cellulose derived from bleached pulp made of wood and having a purity of 90% or more was prepared.
- a cellulose solution was prepared by dissolving cellulose derived from bleached pulp in an ionic liquid.
- the ionic liquid 1-ethyl-3-methylimidazolium diethyl phosphate (manufactured by Aldrich, purity 98%) was used.
- the cellulose solution was diluted with dimethyl sulfoxide.
- a liquid film was formed on the substrate by applying a gap coating and applying a cellulose solution to the surface of the substrate. At this time, the size of the gap in the gap coating was adjusted aiming at the thickness of the bioadhesive film according to Comparative Example 7 being 300 nm.
- the polymer gel sheet was obtained by placing in a 20-60 ° C. 40-60% RH environment. Thereafter, the ionic liquid was removed from the polymer gel sheet by washing the polymer gel sheet. Thereafter, the polymer gel sheet was naturally dried to obtain a regenerated cellulose membrane according to Comparative Example 7 having a thickness of about 300 nm, which can stand by itself.
- the pore volume of pores having a pore diameter of 100 nm or less was 0.44 cm 3 / g.
- the regenerated cellulose membrane according to Comparative Example 7 was placed on the substrate, and from that, fluorescently labeled hyaluronic acid having a molecular weight of 2000-4000 and a molecular weight of 5000-10000 was used as an active ingredient.
- fluorescently labeled hyaluronic acid having a molecular weight of 2000-4000 and a molecular weight of 5000-10000 was used as an active ingredient.
- the contained aqueous solution was dropped and allowed to stand for 30 seconds, penetration of water and penetration of both active ingredients were confirmed.
- FIG. 13 shows the results of evaluating the permeability of hyaluronic acid having a molecular weight of 2000 to 4000 in Example 1 and Comparative Example 1-6.
- FIG. 13 shows that Example 1 has a higher ability to penetrate hyaluronic acid into the skin as compared with Comparative Example 1-6.
- Comparative Example 2 it can be seen that hyaluronic acid can be penetrated in Example 1 even if the film has the same thickness.
- FIG. 14 shows the results of evaluating the permeability of hyaluronic acid having a molecular weight of 5000 to 10,000 in Example 1 and Comparative Example 1-2.
- FIG. 14 shows that even when the molecular weight is 5000-10000, Example 1 has a higher ability to penetrate hyaluronic acid into the skin than Comparative Example 1-2.
- FIG. 15 shows the results of evaluating vitamin C permeability of Example 1 and Comparative Example 1. From FIG. 15, it can be seen that in Example 1, the permeability of vitamin C to the skin is higher than in Comparative Example 2.
- Example 3 Evaluation of adhesion to skin of selective permeable membrane for biological application
- the cellulose film of Example 3 was produced in the same manner as in Example 1 with a target thickness of 100 nm, 200 nm, 500 nm, and 1300 nm.
- the resulting cellulose membrane thicknesses for each target thickness were about 90 nm, about 220 nm, about 510 nm, and about 1340 nm, respectively.
- Comparative Example 8 By adjusting the cellulose concentration in the cellulose solution and the size of the gap, the target thickness was set to 3000 nm and 5000 nm, and a cellulose film of Comparative Example 7 was produced in the same manner as in Example 1. The thickness of the obtained cellulose membrane for each target thickness was about 2700 nm and about 5000 nm, respectively.
- the adhesion when the cellulose film was attached to the skin was evaluated by the following method. First, a small amount of a commercially available lotion was applied to the skin on the inner side of the upper arm, and a sample (cellulose membrane) was stuck thereon. After 5 hours in that state, it was examined whether the sample had fallen off from the skin.
- FIG. 16 is a graph showing the evaluation results regarding the samples of Examples 1 and 3 and Comparative Examples 4 and 8.
- shaft of the graph shown in FIG. 16 shows the ratio of the person from whom the sample on skin fell out among the persons (total 5 persons) to whom the sample was affixed.
- the regenerated cellulose which is a permselective membrane for attaching to a living body
- the regenerated cellulose which is a permselective membrane for attaching to a living body
- the regenerated cellulose can be provided with a thin film having a good adhesion to the skin, in other words, it is difficult to drop off from the skin when the thickness is about 1300 nm or less.
- the permselective membrane with a thickness of 1300 nm or less can be adhered to the skin for a long time without an adhesive, the cosmetic effect can be further maintained.
- the permselective membrane for biological application can be applied to the skin without an adhesive, and further selectively permeates water in an aqueous solution containing the active ingredient, thus increasing the active ingredient concentration on the skin.
- a higher cosmetic effect can be obtained by performing the perforation forming device and / or the iontophoresis device and / or the ultrasonic wave introduction together.
- the permselective membrane for biological application of the present disclosure can be used as, for example, a skin care film for beauty or medical purposes.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Radiology & Medical Imaging (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
- Electrotherapy Devices (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
本開示は、生体貼付け用選択透過膜、経皮吸収キットおよび美容方法に関する。 The present disclosure relates to a permselective membrane for biological application, a transdermal absorption kit, and a cosmetic method.
美容効果を目的として、肌上に有効性成分を保持させ、経皮吸収、つまり皮膚から有効成分を内部へ吸収させるためのシートパックが提案されている。特許文献1では、活性成分を外に放出させず通気性を有する半透膜の層を含む多層技術コンポジットが提案されている。また、特許文献2では、生体適合性の疎水系ポリマー層を含む30-1000nmの粘着剤なしに肌に密着可能な皮膚用自立性美容シートが提案されている。
For the purpose of cosmetic effect, a sheet pack has been proposed for holding active ingredients on the skin and transdermally absorbing, that is, absorbing the active ingredients from the skin.
本開示は水を速やかに選択的に透過する生体貼付け用選択透過膜、経皮吸収キットおよび美容方法を提供する。 The present disclosure provides a permselective membrane for bioadhesion, a percutaneous absorption kit, and a cosmetic method that selectively permeate water quickly.
本開示の生体貼付け用選択透過膜は、自己支持可能な生体貼付け用選択透過膜であって、再生セルロースを含み、20nm以上1300nm以下の厚さを有し、水を選択的に透過する。 The permselective membrane for bioadhesion of the present disclosure is a self-supportable permselective membrane for bioadhesion, includes regenerated cellulose, has a thickness of 20 nm to 1300 nm, and selectively permeates water.
本開示の実施形態によれば、水を選択透過する自己支持型のセルロース膜が提供される。 According to an embodiment of the present disclosure, a self-supporting cellulose membrane that selectively permeates water is provided.
従来の肌上に有効性成分を保持させるためのシートパック等は、肌の蒸れを抑制するために、通気性、つまり、水蒸気透過性を備えている場合がある。しかし、従来のシートパックは液体の水を選択的に透過させることはできなかった。本願発明者は、再生セルロースを含む膜を経皮吸収に利用することを想到し、再生セルロースの構造を検討する過程において、再生セルロースを含む膜が、速やかに液体の水を選択的に透過し得ることを見出した。この特徴を利用すれば、美容等の有効成分を含む水溶液を濃縮させて皮膚に保持させることができ、美容成分を皮膚からより効率よく吸収させることできると考えられる。このような知見に基づき、本願発明者は、新規な生体貼付け用選択透過膜、経皮吸収キットおよび美容方法を想到した。本開示の生体貼付け用選択透過膜、経皮吸収キットおよび美容方法の概要は以下のとおりである。 Conventional sheet packs for retaining active ingredients on the skin may have air permeability, that is, water vapor permeability, in order to suppress the stuffiness of the skin. However, conventional sheet packs cannot selectively permeate liquid water. The present inventor has conceived that a membrane containing regenerated cellulose is used for percutaneous absorption, and in the process of studying the structure of regenerated cellulose, the membrane containing regenerated cellulose quickly permeates liquid water. Found to get. By utilizing this feature, it is considered that an aqueous solution containing an active ingredient such as beauty can be concentrated and held on the skin, and the cosmetic ingredient can be absorbed more efficiently from the skin. Based on such knowledge, the inventor of the present application has come up with a novel permselective membrane for living body application, a transdermal absorption kit, and a cosmetic method. The outlines of the permselective membrane for living body application, the transdermal absorption kit and the cosmetic method of the present disclosure are as follows.
[項目1]
自己支持可能な生体貼付け用選択透過膜であって、再生セルロースを含み、20nm以上1300nm以下の厚さを有し、水を選択的に透過する、生体貼付け用選択透過膜。
[Item 1]
A self-supporting permselective membrane for bioadhesion, which comprises regenerated cellulose, has a thickness of 20 nm to 1300 nm, and selectively permeates water.
[項目2]
前記生体貼付け用選択透過膜は生体適合性を有する、項目1に記載の生体貼付け用選択透過膜。
[Item 2]
The permselective membrane for living body application according to
[項目3]
前記生体貼付け用選択透過膜は、60以上の分子量を有する化合物を実質的に透過しない、項目1または2に記載の生体貼付け用選択透過膜。
[Item 3]
The permselective membrane for bioadhesive according to
[項目4]
前記再生セルロースは、0~12%の結晶化度を有する、項目1から3のいずれかに記載の生体貼付け用選択透過膜。
[Item 4]
4. The permselective membrane for biological application according to any one of
[項目5]
前記生体貼付け用選択透過膜は、50%以上の吸水率を有する、項目1から4のいずれかに記載の生体貼付け用選択透過膜。
[Item 5]
The permselective membrane for bioadhesive according to any one of
[項目6]
前記再生セルロースは、150000以上の重量平均分子量を有する、項目1から5のいずれかに記載の生体貼付け用選択透過膜。
[Item 6]
6. The permselective membrane for biological application according to any one of
[項目7]
項目1から6のいずれかに記載の生体貼付け用選択透過膜と、
イオン導入装置、電気穿孔装置および超音波導入装置からなる群から選択される少なくとも1つと、
を備えた経皮吸収キット。
[Item 7]
The permselective membrane for biological application according to any one of
At least one selected from the group consisting of an iontophoresis device, an electroporation device and an ultrasound introduction device;
A transdermal absorption kit comprising:
[項目8]
前記電気穿孔装置は、一対の電極と、前記一対の電極の一面を覆う少なくとも1つの絶縁層とを含む電極パッドを含む項目7に記載の経皮吸収キット。
[Item 8]
8. The transdermal absorption kit according to item 7, wherein the electroporation device includes an electrode pad including a pair of electrodes and at least one insulating layer covering one surface of the pair of electrodes.
[項目9]
項目1から6のいずれかに記載の生体貼付け用選択透過膜と、皮膚との間に有効成分を含む水溶液を配置する美容方法。
[Item 9]
A cosmetic method in which an aqueous solution containing an active ingredient is placed between the permselective membrane for attaching a living body according to any one of
[項目10]
有効成分を含む水溶液を皮膚に配置するステップと、
前記水溶液の少なくとも一部を覆うように、項目1から6のいずれかに記載の生体貼付け用選択透過膜を皮膚に貼付するステップと、
前記有効成分を前記皮膚から内部へ浸透させるステップと
を含む美容方法。
[Item 10]
Placing an aqueous solution containing an active ingredient on the skin;
Applying the permselective membrane for biological application according to any one of
A cosmetic method comprising the step of allowing the active ingredient to penetrate from the skin into the interior.
[項目11]
前記浸透させるステップは、穿孔形成法、イオン導入法、および超音波導入法からなる群から選ばれる少なくとも1つを用いる項目10に記載の美容方法。
[Item 11]
Item 11. The cosmetic method according to
以下、本開示の実施形態を詳細に説明する。なお、以下で説明する実施形態は、いずれも包括的または具体的な例を示す。以下の実施形態で示される数値、形状、材料、構成要素、構成要素の配置および接続形態、ステップ、ステップの順序などは、一例であり、本開示を限定する主旨ではない。本明細書において説明される種々の態様は、矛盾が生じない限り互いに組み合わせることが可能である。また、以下の実施形態における構成要素のうち、最上位概念を示す独立請求項に記載されていない構成要素については、任意の構成要素として説明される。以下の説明において、実質的に同じ機能を有する構成要素は共通の参照符号で示し、説明を省略することがある。また、図面が過度に複雑になることを避けるために、一部の要素の図示を省略することがある。 Hereinafter, embodiments of the present disclosure will be described in detail. It should be noted that each of the embodiments described below shows a comprehensive or specific example. Numerical values, shapes, materials, components, arrangement and connection forms of components, steps, order of steps, and the like shown in the following embodiments are merely examples, and are not intended to limit the present disclosure. The various aspects described herein can be combined with each other as long as no contradiction arises. In addition, among the constituent elements in the following embodiments, constituent elements that are not described in the independent claims indicating the highest concept are described as optional constituent elements. In the following description, components having substantially the same function are denoted by common reference numerals, and description thereof may be omitted. In addition, in order to avoid the drawing from becoming excessively complicated, illustration of some elements may be omitted.
(生体貼付け用選択透過膜)
本開示の実施形態による生体貼付け用選択透過膜は、再生セルロースを含み、20nm以上1300nm以下の厚さを有する。また、生体貼付け用選択透過膜は、水を選択的に透過し得る。
(Selective permeable membrane for biological application)
The permselective membrane for biological application according to an embodiment of the present disclosure includes regenerated cellulose and has a thickness of 20 nm to 1300 nm. Moreover, the permselective membrane for biological sticking can selectively permeate | transmit water.
再生セルロースは、例えば、実質的に以下の式(I)で表されるセルロースである。ここで、「実質的に式(I)で表されるセルロース」とは、式(I)で表されるセルロースにおけるグルコース残基のヒドロキシル基が90%以上残っているセルロースを意味する。セルロースのグルコース中のヒドロキシル基の割合は、例えば、X線光電子分光(XPS)等の公知の方法で定量できる。また、上記の定義は、セルロースが分岐構造を含んでいてもよいことを意味する。人工的に誘導体化されたセルロースは、典型的には、「実質的に式(I)で表されるセルロース」には該当しない。一方、「実質的に式(I)で表されるセルロース」からは、誘導体化を経て再生されたセルロースが排除されるわけではない。誘導体化を経て再生されたセルロースであっても、「実質的に式(I)で表されるセルロース」に該当することがある。再生セルロースは、未架橋であってもよい。
本明細書において、「再生セルロース」は、天然セルロースに特有の結晶構造Iを持たないセルロースを意味する。セルロースの結晶構造は、X線回折パターンによって確認することが可能である。図1は、天然セルロースのX線回折パターン(CuKα線(50kV、300mA))の一例を示す。図1に示すX線回折パターンでは、結晶構造Iに特有の、14-17°および23°付近のピークが現れている。再生セルロースは、結晶構造IIであることが多く、12°、20°および22°付近にピークを有し、14-17°および23°付近のピークを有しない。 In the present specification, “regenerated cellulose” means cellulose that does not have the crystal structure I unique to natural cellulose. The crystal structure of cellulose can be confirmed by an X-ray diffraction pattern. FIG. 1 shows an example of an X-ray diffraction pattern (CuKα ray (50 kV, 300 mA)) of natural cellulose. In the X-ray diffraction pattern shown in FIG. 1, peaks around 14-17 ° and 23 °, which are peculiar to the crystal structure I, appear. Regenerated cellulose often has a crystalline structure II and has peaks around 12 °, 20 ° and 22 °, and no peaks around 14-17 ° and 23 °.
再生セルロースの原料は、特に限定されない。例えば、再生セルロースの原料は、植物由来の天然セルロース、生物由来の天然セルロース、セロハン等の再生セルロース、又はセルロースナノファイバー等の加工されたセルロースでありうる。再生セルロースの原料における不純物の濃度が10重量%以下であることが有利である。 The raw material of regenerated cellulose is not particularly limited. For example, the raw material of the regenerated cellulose can be plant-derived natural cellulose, bio-derived natural cellulose, regenerated cellulose such as cellophane, or processed cellulose such as cellulose nanofiber. It is advantageous that the concentration of impurities in the raw material of regenerated cellulose is 10% by weight or less.
セルロースは生体適合性に優れ、親水でありながら水に溶けない性質を持つ。特に、再生セルロースは、天然セルロースのナノファイバーよりも小さい単位同士で水素結合が均一に形成されているため、薄くても強度が強い膜を形成し得る。また、分子内に多くの水と相互作用可能な水酸基を持つため、水を選択的に通しやすいと考えられる。本明細書において、生体適合性に優れる、あるいは、生体適合性を有するとは、生体、特に皮膚に発疹、炎症等のかぶれなどの反応を生じさせにくいことをいう。 Cellulose has excellent biocompatibility and is hydrophilic but not soluble in water. In particular, the regenerated cellulose can form a strong film even if it is thin because hydrogen bonds are uniformly formed in units smaller than the nanofibers of natural cellulose. In addition, it has a hydroxyl group capable of interacting with a large amount of water in the molecule, so it is considered that water can easily be selectively passed. In this specification, being excellent in biocompatibility or having biocompatibility means that it is difficult to cause reactions such as rashes and inflammations on the living body, particularly the skin.
上述したように、生体貼付け用選択透過膜は、20nm以上1300nm以下の厚さを有することが好ましい。生体貼付け用選択透過膜が20nm以上の厚さを有することによって、生体貼付け用選択透過膜は自己支持可能である。また、生体貼付け用選択透過膜が1300nm以下の厚さを有することによって、皮膚表面の伸縮や変形に追従し、粘着剤などを用いることなく皮膚に長時間貼付け可能である。更に、1300nm以下の厚さを有することにより、速やかに水を選択的に透過することが可能となる。 As described above, it is preferable that the permselective membrane for bioadhesion has a thickness of 20 nm or more and 1300 nm or less. When the permselective membrane for bioadhesion has a thickness of 20 nm or more, the permselective membrane for bioadhesion can be self-supporting. In addition, since the permselective membrane for bioadhesion has a thickness of 1300 nm or less, it can follow the expansion and contraction of the skin surface and can be applied to the skin for a long time without using an adhesive or the like. Furthermore, by having a thickness of 1300 nm or less, it becomes possible to quickly permeate water quickly.
生体貼付け用選択透過膜の厚みは、50nm以上1000nm以下の厚さを有していてもよい。厚さが50nm以上であると、より高い強度が得られ、生体貼付け用選択透過膜の取り扱いがより容易となる。生体貼付け用選択透過膜の厚さが1000nm以下であると、皮膚に貼付した場合にセルロース膜100が目立たないので有益である。生体貼付け用選択透過膜は、500nm以上1000nm以下の厚さを有していてもよい。厚さが500nm以上であると、より強度が高く破れ難い生体貼付け用選択透過膜が得られる。また、より多くの有効な成分(例えば美容成分)をセルロース膜に保持させることができる。生体貼付け用選択透過膜が100nm以上500nm以下の厚さを有していてもよい。厚さが100nm以上であると、薄膜の形状の維持に有利である。厚さを500nm以下とすることにより、生体貼付け用選択透過膜の密着性をより向上させ得る。したがって、皮膚またはその他の表面に、生体貼付け用選択透過膜をより長く安定に貼り付け得る。また、生体貼付け用選択透過膜がより薄くなることにより、生体貼付け用選択透過膜を皮膚上でより目立たなくすることができる。
The thickness of the permselective membrane for bioadhesion may have a thickness of 50 nm to 1000 nm. When the thickness is 50 nm or more, higher strength is obtained, and handling of the permselective membrane for attaching a living body becomes easier. When the thickness of the permselective membrane for biological application is 1000 nm or less, the
生体貼付け用選択透過膜の厚みは、例えば、生体貼付け用選択透過膜の厚みを複数箇所測定し、平均することによって決定される。各箇所における厚みは、例えば、ブルカー ナノ インコーポレイテッド製 触針式プロファイリングシステムDEKTAK(登録商標)を用いて測定できる。 The thickness of the permselective membrane for bioadhesion is determined by, for example, measuring the thickness of the permselective membrane for bioadhesion at a plurality of locations and averaging. The thickness at each location can be measured using, for example, a stylus profiling system DEKTAK (registered trademark) manufactured by Bruker Nano Inc.
ここで、「自己支持可能」とは、支持体なしに膜としての形態を維持できることを意味する。例えば指、ピンセットなどを用いて膜の一部をつまんでその膜を持ち上げたときに、その膜を破損させることなく、支持体なしにその膜の全体を持ち上げることが可能である。 Here, “self-supportable” means that the form as a film can be maintained without a support. For example, when a part of the film is picked up by using fingers, tweezers or the like and the film is lifted, the whole film can be lifted without a support without damaging the film.
生体貼付け用選択透過膜が再生セルロースを含むことによって、再生セルロースの構造に由来する細孔、および、再生セルロースの繰り返し単位であるグルコースのヒドロキシル基が、生体貼付け用選択透過膜に水の速やかでかつ選択的な透過性を与える。本明細書において、水を選択的に透過するとは、液体の水を透過し、水よりも大きな分子およびイオンを透過しにくい、つまり、実質的に透過しないことをいう。水よりも大きな分子およびイオンは、例えば、60程度以上の分子量を有する。以下の実施例で詳細に説明するように、例えば、水が浸透すると変色する紙上に生体貼付け用選択透過膜を配置し、その上から有効成分を含有した水溶液を滴下した後、30秒後に、紙が水の透過により変色するが、紙から検出される有効成分が、滴下した水溶液の有効成分濃度の1/10以下の濃度であれば、生体貼付け用選択透過膜は水を選択的に透過し、分子量60以上の分子およびイオンを実質的に透過しないと定義される。より好ましくは、透過した水中の有効成分の濃度が1/20以下であり、さらに好ましくは検出限界以下である。有効成分の検出方法としては、質量分析、吸光光度計による分析、有効成分が蛍光体である場合は蛍光顕微鏡による分析などが挙げられる。水の透過速度は、生体貼付け用選択透過膜の厚さに依存する。生体貼付け用選択透過膜が20nm以上1300nm以下の厚さを有する場合、概ね30秒以内に上述した方法によって下に配置した紙の変色が確認し得る。言い換えると、本明細書において、水を選択的に速やかに透過するとは、数十秒以内に目視によって液体の水が生体貼付け用選択透過膜の一方の面から他方の面へ透過したことを確認できる程度の速さで水が透過することをいう。 When the permselective membrane for bioadhesion contains regenerated cellulose, the pores derived from the structure of the regenerated cellulose and the hydroxyl group of glucose, which is a repeating unit of the regenerated cellulose, are rapidly transferred to the permselective membrane for bioadhesive. And gives selective permeability. In this specification, selectively transmitting water means that liquid water is transmitted and molecules and ions larger than water are difficult to be transmitted, that is, substantially not permeated. Molecules and ions larger than water have a molecular weight of, for example, about 60 or more. As will be described in detail in the following examples, for example, after placing a selective permeation membrane for biological application on paper that changes color when water permeates, and dropping an aqueous solution containing an active ingredient on it, 30 seconds later, The paper discolors due to the permeation of water, but if the active ingredient detected from the paper is 1/10 or less of the active ingredient concentration of the dropped aqueous solution, the permselective membrane for biological application selectively permeates water. It is defined as substantially not transmitting molecules and ions having a molecular weight of 60 or more. More preferably, the concentration of the active ingredient in the permeated water is 1/20 or less, more preferably less than the detection limit. Examples of the method for detecting the active ingredient include mass spectrometry, analysis using an absorptiometer, and analysis using a fluorescence microscope when the active ingredient is a phosphor. The permeation rate of water depends on the thickness of the permselective membrane for biological application. When the permselective membrane for bioadhesion has a thickness of 20 nm or more and 1300 nm or less, discoloration of the paper disposed below can be confirmed by the above-described method within approximately 30 seconds. In other words, in the present specification, to selectively permeate water quickly confirms that liquid water has permeated from one surface of the selective permeation membrane for living body application to the other surface by visual observation within several tens of seconds. It means that water permeates as fast as possible.
生体貼付け用選択透過膜に含まれる再生セルロースは、150000以上の重量平均分子量を有することが好ましい。重量平均分子量が150000以上であることにより、1分子鎖あたり、より多くの水酸基が含まれ、より多くの分子間の水素結合が形成されることにより、20nm以上1300nm以下の厚さでありながら、支持体を要することなく形状を維持可能な膜を得ることができる。 It is preferable that the regenerated cellulose contained in the permselective membrane for biological application has a weight average molecular weight of 150,000 or more. By having a weight average molecular weight of 150,000 or more, more hydroxyl groups are included per molecular chain, and more hydrogen bonds between molecules are formed, so that the thickness is 20 nm or more and 1300 nm or less. A membrane capable of maintaining the shape without requiring a support can be obtained.
生体貼付け用選択透過膜は再生セルロールを含んでいればよく、不可避的不純物、原料、他の添加材料などを含んでいてもよい。好ましくは、生体貼付け用選択透過膜は、90質量%以上の割合で再生セルロールを含んでいる。 The permselective membrane for biological application only needs to contain a regenerated cell roll, and may contain inevitable impurities, raw materials, other additive materials, and the like. Preferably, the permselective membrane for bioadhesion contains regenerated cellulose at a ratio of 90% by mass or more.
本開示の実施の形態による生体貼付け用選択透過膜に含まれる再生セルロースは、0~12%の結晶化度を有し得る。後述する例示的な製造方法によれば、0%の結晶化度を有するセルロース膜を得ることも可能である。結晶化度が12%以下であると、結晶の形態の形成に関わる水酸基の割合が適度に低減されることにより、セルロース膜の皮膚への密着性が向上し得る。更に、結晶構造の形成に関わる水酸基の量が適度に少ないことにより、水と相互作用する水酸基が多くなり、より速やかに水を選択透過できる。なお、水酸基が存在すべきサイトにおいて所定の化学修飾がなされることにより、生体貼付け用選択透過膜が様々な機能を発現しうる。 The regenerated cellulose contained in the permselective membrane for biological application according to the embodiment of the present disclosure may have a crystallinity of 0 to 12%. According to an exemplary production method described later, it is possible to obtain a cellulose film having a crystallinity of 0%. When the degree of crystallinity is 12% or less, the adhesion of the cellulose film to the skin can be improved by appropriately reducing the proportion of hydroxyl groups involved in the formation of crystal forms. Furthermore, since the amount of hydroxyl groups involved in the formation of the crystal structure is moderately small, the number of hydroxyl groups that interact with water increases, and water can be selectively permeated more quickly. In addition, by performing a predetermined chemical modification at a site where a hydroxyl group should exist, the permselective membrane for biological application can exhibit various functions.
生体貼付け用選択透過膜は、50%以上の吸水率を持つことが望ましい。吸水率は、JIS K7209に記載と同様の方法により定義される。50%以上の吸水率を持つことにより、生体貼付け用選択透過膜は水を保持し、膜自体の電気抵抗を小さくすることができる。これにより、静電気などを防ぐことが可能となり、空気中の埃や粉塵(花粉やPM2.5など含む)を引き寄せにくくなる効果を示す。吸水率は100%以上であることが、より望ましい。また、膜の厚さが20nm以上1300nm以下であり、電気抵抗が低いことにより、生体貼付け用選択透過膜の抵抗による電圧降下が少なく、イオン導入装置、電気穿孔装置および超音波導入装置を用いて皮膚と生体貼付け用選択透過膜との間に有効成分を含む水溶液を配置した場合、これらの機器による有効成分の皮膚内部への導入の効果をより高めることが可能となる。 It is desirable that the permselective membrane for biological application has a water absorption of 50% or more. The water absorption rate is defined by the same method as described in JIS K7209. By having a water absorption rate of 50% or more, the permselective membrane for living body application can retain water and reduce the electrical resistance of the membrane itself. Thereby, it becomes possible to prevent static electricity etc., and the effect which becomes difficult to attract dust and dust (including pollen, PM2.5, etc.) in the air is shown. The water absorption is more preferably 100% or more. In addition, since the thickness of the membrane is 20 nm or more and 1300 nm or less and the electrical resistance is low, there is little voltage drop due to the resistance of the permselective membrane for living body application, and an iontophoresis device, an electroporation device, and an ultrasound introduction device are used. When an aqueous solution containing an active ingredient is disposed between the skin and the permselective membrane for attaching to a living body, the effect of introducing the active ingredient into the skin by these devices can be further enhanced.
生体貼付け用選択透過膜は、0.3cm3/g以下の細孔容積を有することが好ましい
。細孔容積が0.3cm3/g以下であることにより、生体貼付け用選択透過膜は、高い
水の選択透過性を発揮し得る。更に、0.05cm3/g以下の細孔容積を有することが好ましい。細孔容積が0.05cm3/g以下であることにより、生体貼付け用選択透過
膜は、より高い水の選択透過性を発揮し得る。本明細書での細孔容積とは、100nm以下の細孔径を有する細孔の容積を意味する。細孔容積は、例えばガス吸着法によって決定できる。生体貼付け用選択透過膜は高い透明性を有するため、100nmより大きな細孔はほとんど存在しないと考えられる。生体貼付け用選択透過膜は、例えば0.001cm3/g以上の細孔容積を有する。
The permselective membrane for biological application preferably has a pore volume of 0.3 cm 3 / g or less. When the pore volume is 0.3 cm 3 / g or less, the permselective membrane for biological application can exhibit high water selective permeability. Furthermore, it is preferable to have a pore volume of 0.05 cm 3 / g or less. When the pore volume is 0.05 cm 3 / g or less, the permselective membrane for biological application can exhibit higher water permselectivity. The pore volume in the present specification means the volume of pores having a pore diameter of 100 nm or less. The pore volume can be determined by, for example, a gas adsorption method. Since the permselective membrane for biological application has high transparency, it is considered that there are almost no pores larger than 100 nm. The permselective membrane for biological application has a pore volume of, for example, 0.001 cm 3 / g or more.
本実施形態の生体貼付け用選択透過膜によれば、20nm以上1300nm以下の厚さを有することによって、かぶれなどの原因であった粘着剤なしに、化粧水や美容液などのみで膜を生体に長時間貼り付けることが可能となる。また、生体貼付け用選択透過膜の主成分が再生セルロースであるため、生体適合性に優れ、生体に負担無く長時間使用することが可能となる。 According to the permselective membrane for living body application of this embodiment, having a thickness of 20 nm or more and 1300 nm or less, the membrane can be made into a living body only with skin lotion or cosmetic liquid without the adhesive that caused the rash. It can be applied for a long time. In addition, since the main component of the permselective membrane for bioadhesion is regenerated cellulose, it is excellent in biocompatibility and can be used for a long time without any burden on the living body.
また、生体貼付け用選択透過膜は水を選択的に透過し得るため、生体と生体貼付け用選択透過膜との間に医用または美容用の有効成分を含む水溶液を配置すれは、水溶液の溶媒である水が選択的に生体貼付け用選択透過膜を透過し、生体貼付け用選択透過膜の表面に浮き出る。このため、生体と接する水溶液の溶媒が減少することにより、有効成分の濃度が高められ、濃度勾配により生体により浸透されやすくなる。 In addition, since the permselective membrane for living body application can selectively permeate water, an aqueous solution containing an active ingredient for medical or cosmetic use is placed between the living body and the permselective membrane for attaching living body. A certain water selectively permeates through the permselective membrane for bioadhesion and floats on the surface of the permselective membrane for bioadhesion. For this reason, when the solvent of the aqueous solution in contact with the living body is reduced, the concentration of the active ingredient is increased, and the concentration of the active ingredient is increased due to the concentration gradient.
再生セルロースは分子内または/および分子間で水素結合が形成されやすく、薄くても高い強度を有し、かつ、適度な柔軟性及び破れにくい膜を得ることが出来る。また、膜中に美容成分等の有効成分を担持することも出来る。再生セルロースは、両親媒性を示すので、親水性の有効成分及び疎水性の有効成分を適切に担持できる。有効成分は美容成分に限られず医用成分であってもよい。 Regenerated cellulose can easily form hydrogen bonds within the molecule and / or between the molecules, has a high strength even if it is thin, and can obtain an appropriate flexibility and a film that is not easily broken. In addition, active ingredients such as cosmetic ingredients can be carried in the film. Since regenerated cellulose exhibits amphiphilic properties, it can appropriately carry a hydrophilic active ingredient and a hydrophobic active ingredient. The active ingredient is not limited to a cosmetic ingredient but may be a medical ingredient.
本開示の実施形態による生体貼付け用選択透過膜は、例えば顔、腕などの皮膚に貼付されて使用され得る。本開示の実施形態による生体貼付け用選択透過膜は、典型的には、7mm2以上の面積を有する。セルロース膜の面積が7mm2以上であると、皮膚に貼付する場合、より大きな領域を覆えるので有益である。また、本開示の生体貼付け用選択透過膜は、皮膚以外の生体にも適用することができ、例えば、臓器の表面に貼付してもよい。 The permselective membrane for bioadhesion according to an embodiment of the present disclosure can be used by being affixed to skin such as a face or an arm. The permselective membrane for biological application according to an embodiment of the present disclosure typically has an area of 7 mm 2 or more. When the area of the cellulose membrane is 7 mm 2 or more, it is beneficial because it covers a larger area when applied to the skin. Moreover, the permselective membrane for bioadhesion of the present disclosure can be applied to a living body other than skin, and may be applied to the surface of an organ, for example.
生体貼付け用選択透過膜は、例えば、23MPa以上の引張り強さを有する。この場合、例えば、生体貼付け用選択透過膜は皮膚に貼り付けても容易に破れることがなく、長期間皮膚に貼り付けておくことが出来る。また、本開示の生体貼付け用選択透過膜は、少なくとも一部が着色されていてもよい。 The permselective membrane for biological application has a tensile strength of 23 MPa or more, for example. In this case, for example, the permselective membrane for living body application is not easily broken even if it is applied to the skin, and can be applied to the skin for a long time. In addition, the permselective membrane for bioadhesion of the present disclosure may be at least partially colored.
生体貼付け用選択透過膜は、例えば、以下の方法 によって製造することができる。ま
ず、溶媒にセルロースを溶解させてセルロース溶液を調製する。150,000以上の重
量平均分子量の再生セルロース膜を得るために、重量平均分子量が少なくとも150,000以上のセルロースを用いてセルロース溶液を調製してもよい。この場合、1300nm以下の厚み有する自己支持型の生体貼付け用選択透過膜を作製できる。このように、セルロース溶液の調製において使用されるセルロースの重量平均分子量を150000以上にすることにより、1分子鎖において、より多くの水酸基が含まれることにより、多くの分子間水素結合を形成することが可能となることで、1300nm以下の生体貼付け用選択透過膜を安定に作製することができる。セルロース溶液の調製に使用するセルロースは、所望の重量平均分子量を有する限り、特に制限されない。
The permselective membrane for biological application can be produced, for example, by the following method. First, cellulose is dissolved in a solvent to prepare a cellulose solution. In order to obtain a regenerated cellulose membrane having a weight average molecular weight of 150,000 or more, a cellulose solution may be prepared using cellulose having a weight average molecular weight of at least 150,000 or more. In this case, a self-supporting permselective membrane for attaching a living body having a thickness of 1300 nm or less can be produced. In this way, by forming the weight average molecular weight of cellulose used in the preparation of the cellulose solution to be 150,000 or more, more intermolecular hydrogen bonds are formed by including more hydroxyl groups in one molecular chain. Therefore, it is possible to stably produce a permselective membrane for bioadhesion of 1300 nm or less. The cellulose used for preparing the cellulose solution is not particularly limited as long as it has a desired weight average molecular weight.
溶液の調整に使用するセルロースとしては、天然セルロースおよび再生セルロースのいずれをも用い得る。セルロースは、例えば、パルプ及び綿花等の植物由来のセルロース、又は、バクテリア等の生物が生成したセルロースでありうる。セルロースの原料における不純物濃度は、例えば10重量%以下である。再生セルロースの重量平均分子量は、2,
000,000以下であると取り扱いが容易となるため有用である。更に望ましくは再生
セルロースの重量平均分子量は1,000,000以下である。
As the cellulose used for preparing the solution, any of natural cellulose and regenerated cellulose can be used. Cellulose can be, for example, cellulose derived from plants such as pulp and cotton, or cellulose produced by organisms such as bacteria. The impurity concentration in the cellulose raw material is, for example, 10% by weight or less. The weight average molecular weight of regenerated cellulose is 2,
Since it is easy to handle when it is 000,000 or less, it is useful. More desirably, the regenerated cellulose has a weight average molecular weight of 1,000,000 or less.
溶媒は、例えば少なくともイオン液体を含有している溶媒(第1溶媒)である。第1溶媒を用いることにより、セルロースを比較的短時間で溶解させることができる。イオン液体は、アニオンとカチオンとから構成される塩であり、150℃以下の温度において液体状態を示しうる。第1溶媒に含まれるイオン液体は、例えば、アミノ酸又はアルキルリン酸エステルを含むイオン液体である。第1溶媒がこのようなイオン液体を含有していることにより、セルロースの分子量の低下を抑制しながらセルロースを溶解させることができる。特に、アミノ酸は、生体内に存在する成分であるので、アミノ酸を含むイオン液体は、生体に対してより安全な生体貼付け用選択透過膜を製造するのに有利である。 The solvent is, for example, a solvent (first solvent) containing at least an ionic liquid. By using the first solvent, cellulose can be dissolved in a relatively short time. An ionic liquid is a salt composed of an anion and a cation, and can exhibit a liquid state at a temperature of 150 ° C. or lower. The ionic liquid contained in the first solvent is, for example, an ionic liquid containing an amino acid or an alkyl phosphate ester. When the first solvent contains such an ionic liquid, cellulose can be dissolved while suppressing a decrease in the molecular weight of cellulose. In particular, since an amino acid is a component that exists in a living body, an ionic liquid containing the amino acid is advantageous for producing a permselective membrane for biological application that is safer for a living body.
セルロースを析出させない溶媒によって予め希釈されたイオン液体を用いてセルロースを溶解してもよい。例えば、第1溶媒として、非プロトン性極性溶媒とイオン液体との混合物を用いてもよい。非プロトン性極性溶媒は、水素結合を形成しにくく、セルロースを析出させにくい。 The cellulose may be dissolved by using an ionic liquid diluted in advance with a solvent that does not precipitate the cellulose. For example, a mixture of an aprotic polar solvent and an ionic liquid may be used as the first solvent. The aprotic polar solvent hardly forms hydrogen bonds and does not easily precipitate cellulose.
第1溶媒に含まれるイオン液体は、例えば、下記の式(II)で表されるイオン液体である。式(II)で表されるイオン液体において、アニオンがアミノ酸である。式(II)に記載の通り、このイオン液体において、アニオンは、末端カルボキシル基及び末端アミノ基を含んでいる。式(II)で表されるイオン液体のカチオンは、第四級アンモニウムカチオンであってもよい。
式(II)中、R1~R6は、独立して、水素原子又は置換基を表す。置換基は、アルキル基、ヒドロキシアルキル基、又はフェニル基でありうる。置換基は、炭素鎖に分岐を含んでいてもよい。置換基は、アミノ基、ヒドロキシル基、又はカルボキシル基等の官能基を含んでいてもよい。nは、例えば、4又は5である。 In the formula (II), R1 to R6 independently represent a hydrogen atom or a substituent. The substituent can be an alkyl group, a hydroxyalkyl group, or a phenyl group. The substituent may contain a branch in the carbon chain. The substituent may contain a functional group such as an amino group, a hydroxyl group, or a carboxyl group. n is, for example, 4 or 5.
第1溶媒に含まれるイオン液体は、下記の式(III)で表されるイオン液体であっても
よい。式(III)中、R1、R2、R3、及びR4は、独立して、水素原子又は1~4個の炭
素原子を有するアルキル基を表す。
セルロース溶液を調製する工程において、第2溶媒をさらに加えてもよい。例えば、所定の重量平均分子量を有するセルロースと第1溶媒との混合物に第2溶媒をさらに加えてもよい。第2溶媒は、例えば、セルロースを析出させない溶媒である。第2溶媒は、例えば非プロトン性極性溶媒でありうる。 In the step of preparing the cellulose solution, a second solvent may be further added. For example, the second solvent may be further added to a mixture of cellulose having a predetermined weight average molecular weight and the first solvent. The second solvent is, for example, a solvent that does not precipitate cellulose. The second solvent can be, for example, an aprotic polar solvent.
セルロース溶液のセルロースの濃度は、典型的には、0.2~15重量%である。セルロース溶液のセルロースの濃度が0.2重量%以上であれば、生体貼付け用選択透過膜の厚みを薄くしつつ、その形状を保つのに必要な強度を有する生体貼付け用選択透過膜が得られる。また、セルロース溶液のセルロースの濃度が15重量%以下であれば、セルロース溶液におけるセルロースの析出を抑制できる。セルロース溶液のセルロースの濃度は、1~10重量%であってもよい。セルロース溶液のセルロースの濃度が1重量%以上であると、より高い強度を有する生体貼付け用選択透過膜が得られる。セルロース溶液のセルロースの濃度が10重量%以下であると、セルロースの析出がより低減された安定したセルロース溶液を調製できる。 The concentration of cellulose in the cellulose solution is typically 0.2 to 15% by weight. If the cellulose concentration of the cellulose solution is 0.2% by weight or more, a biopermeable selective permeable membrane having a strength necessary for maintaining the shape of the biopermeable selective permeable membrane can be obtained while reducing the thickness of the biopermeable selective permeable membrane. . Moreover, if the density | concentration of the cellulose of a cellulose solution is 15 weight% or less, precipitation of the cellulose in a cellulose solution can be suppressed. The cellulose concentration of the cellulose solution may be 1 to 10% by weight. When the concentration of cellulose in the cellulose solution is 1% by weight or more, a permselective membrane for bioadhesion having higher strength can be obtained. When the concentration of cellulose in the cellulose solution is 10% by weight or less, a stable cellulose solution in which precipitation of cellulose is further reduced can be prepared.
次に、基板の表面にセルロース溶液を塗布して、基板の表面上に液膜を形成する。基板の表面の水に対する接触角は、例えば90°以下である。この場合、セルロース溶液の基板に対する濡れ性が適切であり、基板の表面に沿って広がりのある液膜を安定的に形成できる。基板の材料は、特に限定されない。基板は、典型的には、平滑な表面を有する非多孔構造を有する。この場合、基板の内部にセルロース溶液が入り込むことを防止でき、後工程において生体貼付け用選択透過膜を基板から分離しやすい。基板は、化学的又は物理的な表面改質されていてもよい。基板として、例えば、紫外線(UV)照射又はコロナ処理等の表面改質処理がなされたポリマー材料の基板を用いてもよい。表面改質の方法は特に限定されない。例えば、表面改質剤の塗布、表面修飾、プラズマ処理、スパッタリング、エッチング、又はブラストが適用されうる。 Next, a cellulose solution is applied to the surface of the substrate to form a liquid film on the surface of the substrate. The contact angle with respect to the water of the surface of a board | substrate is 90 degrees or less, for example. In this case, the wettability of the cellulose solution to the substrate is appropriate, and a liquid film that spreads along the surface of the substrate can be stably formed. The material of the substrate is not particularly limited. The substrate typically has a non-porous structure with a smooth surface. In this case, it is possible to prevent the cellulose solution from entering the inside of the substrate, and it is easy to separate the permselective membrane for biological application from the substrate in a subsequent process. The substrate may be chemically or physically surface modified. As the substrate, for example, a polymer material substrate that has been subjected to surface modification treatment such as ultraviolet (UV) irradiation or corona treatment may be used. The method for surface modification is not particularly limited. For example, application of a surface modifier, surface modification, plasma treatment, sputtering, etching, or blasting can be applied.
基板にセルロース溶液の液膜を形成する方法は、例えば、アプリケータなどにより基板の表面との間に所定のギャップを形成するギャップコーティング、スロットダイコーティング、スピンコーティング、バーコーターを用いたコーティング(Metering rod coating)、及びグラビアコーティング等の方法である。ギャップの厚みまたはスロットダイの開口の大きさと塗工スピード、またはスピンコートの回転数、バーコーターやグラビアコートの溝の深さや塗工スピードなどにより調整した液膜の厚みと、セルロース溶液の濃度を調整することによって、生体貼付け用選択透過膜の厚みを調整可能である。なお、基板にセルロース溶液の液膜を形成する方法は、キャスティング法、スキージを用いたスクリーン印刷、吹付塗装、又は静電噴霧であってもよい。 A method for forming a liquid film of a cellulose solution on a substrate includes, for example, gap coating, slot die coating, spin coating, coating using a bar coater (Metering) that forms a predetermined gap with the surface of the substrate by an applicator or the like. rod coating) and gravure coating. The thickness of the liquid film adjusted by the gap thickness or slot die opening size and coating speed, spin coating speed, bar coater or gravure coating groove depth and coating speed, etc., and the concentration of the cellulose solution. By adjusting, the thickness of the permselective membrane for biological application can be adjusted. The method for forming the liquid film of the cellulose solution on the substrate may be a casting method, screen printing using a squeegee, spray coating, or electrostatic spraying.
基板にセルロース溶液の液膜を形成するときに、セルロース溶液及び基板の少なくとも一方を加熱してもよい。この加熱は、例えば、セルロース溶液を安定に保つことができる温度範囲(例えば、40~100℃)で実施されても良い。 When forming a liquid film of the cellulose solution on the substrate, at least one of the cellulose solution and the substrate may be heated. This heating may be performed, for example, in a temperature range (for example, 40 to 100 ° C.) in which the cellulose solution can be kept stable.
基板に形成されたセルロース溶液の液膜は、加熱されてもよい。液膜の加熱は、例えば、第1溶媒に含まれるイオン液体の分解温度よりも低い温度(例えば、50~200℃)でなされる。液膜の加熱は、イオン液体の分解温度よりも低く、かつ、第2溶媒の沸点よりも低い温度でなされてもよい。このような温度で液膜の加熱を実行することにより、イオン液体以外の溶媒(例えば、第二溶媒など)を適度に除去でき、生体貼付け用選択透過膜の強度及び再生セルロースのかさ密度が高くなりやすい。加えて、セルロース溶液中の溶媒の突沸に起因する、生体貼付け用選択透過膜の品質低下を抑制できる。液膜の加熱は、減圧環境下で実行されてもよい。この場合、溶媒の沸点よりも低い温度でイオン液体以外の溶媒をより短時間で適度に除去できる。 The liquid film of the cellulose solution formed on the substrate may be heated. The liquid film is heated, for example, at a temperature lower than the decomposition temperature of the ionic liquid contained in the first solvent (for example, 50 to 200 ° C.). The heating of the liquid film may be performed at a temperature lower than the decomposition temperature of the ionic liquid and lower than the boiling point of the second solvent. By performing the heating of the liquid membrane at such a temperature, a solvent other than the ionic liquid (for example, the second solvent) can be appropriately removed, and the strength of the selective permeable membrane for biological application and the bulk density of regenerated cellulose are high. Prone. In addition, it is possible to suppress deterioration in the quality of the permselective membrane for biological application due to bumping of the solvent in the cellulose solution. The heating of the liquid film may be performed under a reduced pressure environment. In this case, a solvent other than the ionic liquid can be appropriately removed in a shorter time at a temperature lower than the boiling point of the solvent.
基板にセルロース溶液の液膜を形成した後に、液膜はゲル化されてもよい。例えば、イオン液体に溶解可能であり、かつ、セルロースを溶解させない液体の蒸気に液膜を曝すことにより、液膜をゲル化させ、高分子ゲルシートを得ることができる。例えば、30~100%RHの相対湿度の環境下に液膜を放置すると、液膜中のイオン液体が水と接触することにより、液膜におけるセルロースの溶解度が低下する。これにより、セルロース分子の一部が析出し、3次元構造が形成される。その結果、液膜がゲル化する。ゲル化点の有無は、ゲル化した膜を持ち上げることが可能か否かによって判断できる。 After the liquid film of the cellulose solution is formed on the substrate, the liquid film may be gelled. For example, by exposing the liquid film to vapor of a liquid that is soluble in an ionic liquid and does not dissolve cellulose, the liquid film can be gelled to obtain a polymer gel sheet. For example, when a liquid film is left in an environment with a relative humidity of 30 to 100% RH, the ionic liquid in the liquid film comes into contact with water, so that the solubility of cellulose in the liquid film decreases. Thereby, a part of cellulose molecule precipitates and a three-dimensional structure is formed. As a result, the liquid film is gelled. The presence or absence of a gel point can be determined by whether or not the gelled film can be lifted.
ゲル化の工程の条件により、最終的に得られるセルロース膜の結晶化度を調整し得る。例えば、相対湿度が60%RH以下の環境でゲル化を行うと、ゲル化が徐々に進行するために、セルロース分子の3次元構造体を安定に形成しやすく、結晶化度を安定に低下させ得る。相対湿度が40%RH以下の環境下では、より結晶化度が低減された再生セルロース膜を得ることが可能である。 The crystallinity of the cellulose film finally obtained can be adjusted according to the conditions of the gelation process. For example, when gelation is performed in an environment where the relative humidity is 60% RH or less, the gelation gradually proceeds, so that it is easy to stably form a three-dimensional structure of cellulose molecules, and the crystallinity is stably reduced. obtain. In an environment where the relative humidity is 40% RH or less, it is possible to obtain a regenerated cellulose membrane with a further reduced crystallinity.
なお、液膜の加熱は、液膜のゲル化の前に行われてもよいし、液膜のゲル化の後に行われてもよいし、液膜のゲル化の前後で行われてもよい。 The heating of the liquid film may be performed before gelling of the liquid film, may be performed after gelling of the liquid film, or may be performed before or after gelling of the liquid film. .
次に、セルロースを溶解させない液体であるリンス液に、基板及び高分子ゲルシートを浸漬させる。この工程において、高分子ゲルシートからイオン液体が除去される。この工程は、高分子ゲルシートの洗浄の工程と理解される。この工程において、イオン液体に加えて、セルロース溶液に含まれていた成分のうち、セルロース及びイオン液体以外の成分(例えば、第2溶媒)の一部が除去されてもよい。この工程において、リンス液を複数回交換してもよい。リンス液は、典型的には、イオン液体に溶解可能な液体である。このような液体の例は、水、メタノール、エタノール、プロパノール、ブタノール、オクタノール、トルエン、キシレン、アセトン、アセトニトリル、ジメチルアセトアミド、ジメチルホルムアミド、及びジメチルスルホキシドである。 Next, the substrate and the polymer gel sheet are immersed in a rinsing liquid that does not dissolve cellulose. In this step, the ionic liquid is removed from the polymer gel sheet. This step is understood as a step of washing the polymer gel sheet. In this step, in addition to the ionic liquid, a part of the components (for example, the second solvent) other than the cellulose and the ionic liquid may be removed from the components contained in the cellulose solution. In this step, the rinsing liquid may be replaced a plurality of times. The rinse liquid is typically a liquid that can be dissolved in an ionic liquid. Examples of such liquids are water, methanol, ethanol, propanol, butanol, octanol, toluene, xylene, acetone, acetonitrile, dimethylacetamide, dimethylformamide, and dimethyl sulfoxide.
次に、高分子ゲルシートから溶媒等の不要な成分を除去する。換言すると、高分子ゲルシートを乾燥させる。このとき、高分子ゲルシートを保護層などの上において乾燥させても良い。高分子ゲルシートの乾燥方法として、自然乾燥、真空乾燥、加熱乾燥、凍結乾燥、及び超臨界乾燥等の乾燥方法を適用できる。高分子ゲルシートの乾燥方法は真空加熱であってもよい。高分子ゲルシートの乾燥の条件は、特に限定されない。高分子ゲルシートの乾燥の条件として、第2溶媒及びリンス液等の不要な成分の除去に十分な時間及び温度が選択される。高分子ゲルシートから不要な成分が除去されることによって、再生セルロース膜が得られる。高分子ゲルシートの乾燥工程において、高分子ゲルシートを所定の力
で引っ張ってもよい。この場合、高分子ゲルシートに加わる引っ張り力の大きさを調整することによって、再生セルロース膜の細孔容積や形状、及び再生セルロースのかさ密度等を所望の状態に調節できる。
Next, unnecessary components such as a solvent are removed from the polymer gel sheet. In other words, the polymer gel sheet is dried. At this time, the polymer gel sheet may be dried on a protective layer or the like. As a method for drying the polymer gel sheet, drying methods such as natural drying, vacuum drying, heat drying, freeze drying, and supercritical drying can be applied. The polymer gel sheet may be dried by vacuum heating. The conditions for drying the polymer gel sheet are not particularly limited. As a condition for drying the polymer gel sheet, a time and temperature sufficient for removing unnecessary components such as the second solvent and the rinse liquid are selected. By removing unnecessary components from the polymer gel sheet, a regenerated cellulose membrane is obtained. In the drying process of the polymer gel sheet, the polymer gel sheet may be pulled with a predetermined force. In this case, the pore volume and shape of the regenerated cellulose membrane, the bulk density of the regenerated cellulose, and the like can be adjusted to a desired state by adjusting the magnitude of the tensile force applied to the polymer gel sheet.
高分子ゲルシートを乾燥させる工程において、例えば、凍結乾燥を適用する場合、凍結可能であり、かつ、100~200℃付近の沸点を有する溶媒が用いられる。例えば、水、tert-ブチルアルコール、酢酸、1,1,2,2,3,3,4-ヘプタフルオロシクロペンタン、又はジメチルスルホキシド等の溶媒を利用して凍結乾燥を行うことができる。凍結乾燥に用いる溶媒が、リンス液に溶解可能な溶媒であると有利である。ただし、凍結乾燥に用いる溶媒が、リンス液に溶解できないような溶媒であっても、高分子ゲルシートのリンス液への浸漬の工程の後、高分子ゲルシート中のリンス液をリンス液に溶解可能な溶媒に置換し、さらに、その溶媒を凍結乾燥のための溶媒に置換することにより、凍結乾燥を実施することが可能である。 In the step of drying the polymer gel sheet, for example, when lyophilization is applied, a solvent that can be frozen and has a boiling point of about 100 to 200 ° C. is used. For example, lyophilization can be performed using a solvent such as water, tert-butyl alcohol, acetic acid, 1,1,2,2,3,3,4-heptafluorocyclopentane, or dimethyl sulfoxide. The solvent used for lyophilization is advantageously a solvent that can be dissolved in the rinse solution. However, even if the solvent used for lyophilization is a solvent that cannot be dissolved in the rinse solution, the rinse solution in the polymer gel sheet can be dissolved in the rinse solution after the step of immersing the polymer gel sheet in the rinse solution. It is possible to carry out lyophilization by substituting with a solvent and further substituting the solvent with a solvent for lyophilization.
美容成分等の有効成分を保持させるために、高分子ゲルシートの乾燥させる工程の前または/および後に成分の溶液に浸漬させることがきる。このとき、溶液には複数の有効成分を含んでいてもよい。溶液における溶媒は、例えば、水、メタノール、エタノール、プロパノール、ブタノール、オクタノール、トルエン、キシレン、アセトン、アセトニトリル、ジメチルアセトアミド、ジメチルホルムアミド、及びジメチルスルホキシドからなる群から選択される少なくとも1つが使用できる。溶液への高分子ゲルシートの浸漬に代えて、噴霧法、蒸着または塗工によって高分子ゲルシートに粘着成分を付着させてもよい。 In order to retain an active ingredient such as a cosmetic ingredient, it can be immersed in the ingredient solution before and / or after the step of drying the polymer gel sheet. At this time, the solution may contain a plurality of active ingredients. As the solvent in the solution, for example, at least one selected from the group consisting of water, methanol, ethanol, propanol, butanol, octanol, toluene, xylene, acetone, acetonitrile, dimethylacetamide, dimethylformamide, and dimethylsulfoxide can be used. Instead of immersing the polymer gel sheet in the solution, an adhesive component may be attached to the polymer gel sheet by spraying, vapor deposition, or coating.
(美容方法)
本開示の実施形態による美容方法は、上述した生体貼付け用選択透過膜と、皮膚との間に有効成分を含む水溶液を配置する。水溶液は水を含んでいれば、溶液、分散液、又はエマルジョンの状態でも良い。
(Beauty method)
In the cosmetic method according to the embodiment of the present disclosure, an aqueous solution containing an active ingredient is disposed between the above-described permselective membrane for biological application and the skin. The aqueous solution may be in the form of a solution, a dispersion, or an emulsion as long as it contains water.
有効成分とは、皮膚に保湿、美白などの美容効果を示す成分であり、例えばアラビアガム、トラガカントガム、ガラクタン、グアガム、キャロブガム、カラヤガム、カラギーナン、ペクチン、カンテン、クインスシード(マルメロ)、アルゲコロイド(カッソウエキス)、デンプン(コメ、トウモロコシ、バレイショ、コムギ)等の植物由来高分子、キサンタンガム、デキストラン、サクシノグルカン、ブルラン等の微生物由来高分子、コラーゲン、カゼイン、アルブミン、ゼラチン等の動物由来高分子、ヒアルロン酸、ムチン、コンドロイチン硫酸、可溶性コラーゲン等の生物由来高分子化合物、ポリエチレングリコール、ソルビトール、キシリトール、マルチトース、dl-ピロリドンカルボン酸ナトリウム、乳酸ナトリウム、トリメチルグリシン、レチノール、レチナール、レチノイン酸等のビタミンA、チアミン、リボフラビン、ピリドキシン、ピリドキサミン、葉酸等のビタミンB、エルゴカルシフェロール、コレカルシフェロール等のビタミンD、α-トコフェロール(ビタミンE)フィロキノン、メナキノンのビタミンK等で代表されるビタミンやトレチノイン、パルミチン酸レチノール等のビタミンA誘導体、グリセリルアスコルビン酸やテトラヘキシルデカン酸アスコルビル等のビタミンC誘導体、アスコルビン酸およびその塩、酢酸α―トコフェロール、α―トコフェリルキノン、コハク酸α―トコフェロール等のビタミンE誘導体、トラネキサム酸、アルブチン、ハイドロキノン、コウジ酸、4-メトキシサリチル酸カリウム、トラネキサム酸、ルシノール、エラグ酸やアントシアニン等のポリフェノール、3-サクシニルオキシグリチルレチン酸二ナトリウム、ルチン、ミノキシジル、フィナステリド、セファランチン、ピロリドンカルボン酸などが挙げられる。 An active ingredient is an ingredient which shows cosmetic effects such as moisturizing and whitening on the skin. For example, gum arabic, tragacanth gum, galactan, guar gum, carob gum, caraya gum, carrageenan, pectin, agar, quince seed (malmello), algae colloid (gasso extract) ), Starch (rice, corn, potato, wheat), etc., plant-derived polymers, xanthan gum, dextran, succinoglucan, bullulan and other microorganism-derived polymers, collagen, casein, albumin, gelatin and other animal-derived polymers, hyaluron Biological polymer compounds such as acid, mucin, chondroitin sulfate, soluble collagen, polyethylene glycol, sorbitol, xylitol, maltose, sodium dl-pyrrolidonecarboxylate, sodium lactate, trime Vitamin A such as luglycine, retinol, retinal, retinoic acid, vitamin B such as thiamine, riboflavin, pyridoxine, pyridoxamine, folic acid, vitamin D such as ergocalciferol, cholecalciferol, α-tocopherol (vitamin E) phylloquinone, menaquinone Vitamins represented by vitamin K and the like, tretinoin, vitamin A derivatives such as retinol palmitate, vitamin C derivatives such as glyceryl ascorbic acid and ascorbyl tetrahexyl decanoate, ascorbic acid and its salts, α-tocopherol acetate, α-tocopherylquinone Vitamin E derivatives such as α-tocopherol succinate, tranexamic acid, arbutin, hydroquinone, kojic acid, potassium 4-methoxysalicylate, tranexamic acid, lucinol, Examples thereof include polyphenols such as ellagic acid and anthocyanins, disodium 3-succinyloxyglycyrrhetinate, rutin, minoxidil, finasteride, cephalanthin and pyrrolidone carboxylic acid.
水を選択的に透過する生体貼付け用選択透過膜と皮膚との間に有効成分が含まれる水溶液を配置することにより、水だけが速やかに生体貼付け用選択透過膜を透過し、皮膚上に
有効成分を濃縮し、皮膚から内部へ有効成分が浸透しやすくなる効果を示す。つまり、経皮吸収効果を高めることができる。
By placing an aqueous solution containing an active ingredient between the skin and the selective permeable membrane for biological application that selectively permeates water, only water quickly penetrates the selective permeable membrane for biological application and is effective on the skin. Concentrates the ingredients, showing the effect that the active ingredients can easily penetrate from the skin to the inside. That is, the transdermal absorption effect can be enhanced.
(経皮吸収キットを用いた美容方法)
本開示の実施形態による経皮キットは、上記生体貼付け用選択透過膜と、イオン導入装置、電気穿孔(エレクトロポーレーション)装置および超音波導入装置からなる群から選択される少なくとも1つとを含む。これらを用いることにより、一般的に皮膚に浸透し難いと考えられている、分子量500以上の有効成分を、肌に浸透し易くすることができる。
(Cosmetics using a transdermal absorption kit)
A transcutaneous kit according to an embodiment of the present disclosure includes the permselective membrane for biological application, and at least one selected from the group consisting of an iontophoresis device, an electroporation device, and an ultrasound introduction device. By using these, an active ingredient having a molecular weight of 500 or more, which is generally considered difficult to penetrate into the skin, can be easily penetrated into the skin.
図2は、電気穿孔装置に用いられる電極パッド10の一例を示す。電極パッド10は、第1電極23および第2電極24と、第1電極23および第2電極24の一面に配置される絶縁層21a、21b、および、第1電極23および第2電極24の他の面に配置される絶縁層25a、25bとを含む。電極10が絶縁層25a、25bを備えていることによって電流が生体に流れることを防ぎ、傷みを感じることなく、施術することが可能である。
FIG. 2 shows an example of the
図3Aから図3Cは、経皮吸収キットを用いた美容方法を説明する図である。図3Aに示すように、まず、皮膚30に有効成分が含まれる水溶液40を塗布する。次に、図3Bに示すように、水溶液40を覆うように生体貼付け用選択透過膜100を皮膚30に貼付ける。さらに生体貼付け用選択透過膜100上に電極パッド10を配置する。
FIG. 3A to FIG. 3C are views for explaining a cosmetic method using a transdermal absorption kit. As shown in FIG. 3A, first, an
次に図3Bに示すように、電極パッド10の第1電極23および第2電極24を電気穿孔装置本体60に接続し、電気穿孔装置を動作させる。電極パッド10を介して皮膚30には電気パルスが印加される。これにより、皮膚30の表面に微小な穴が一時的に形成され、穴を介して有効成分を内部へ浸透させる。この時、生体貼付け用選択透過膜100は、水溶液40中の水を選択的に透過するため、皮膚30に接している水溶液40中の有効成分が濃縮される。このため、高濃度で皮膚に接している有効成分が、電気穿孔法によってより内部へ浸透しやすくなる。
Next, as shown in FIG. 3B, the
図3Cはイオン導入装置70を含む経皮キットの使用方法を示す。電気穿孔装置の使用方法と同様、皮膚30の表面に有効成分を含む水溶液40を塗布し、水溶液40を覆うように生体貼付け用選択透過膜100を皮膚30に貼付ける。その後、生体貼付け用選択透過膜100にイオン導入装置70のヘッド70aを接触させる。この状態で、イオン導入装置70を動作させると、イオン導入装置70のグリップ70bを使用者が手で握ることによって、破線で示すように、使用者とイオン導入装置70との間で電流経路が形成され、ヘッド70aから生体に微弱な電流が流れる。この電流経路に従って、有効成分を生体へ浸透させる。特に有効成分がイオンであり、有効成分の電荷と電流の向きを適切に選択することによって効率的に、有効成分を皮膚30の内部に浸透させることができる。この時、生体貼付け用選択透過膜100は、水溶液40中の水を選択的に透過するため、生体30に接している水溶液40中の有効成分が濃縮される。このため、高濃度で皮膚に接している有効成分が、イオン導入法によって、より内部へ浸透しやすくなる。
FIG. 3C shows how to use the transdermal kit including the
イオン導入装置および電気穿孔装置は独立して使用できるが、併用してもよい。この場合、例えば、まず、電気穿孔装置を用いて皮膚に一時的な穴を形成した後、イオン導入装置を用いると、形成された穴から有効成分をより効率的に生体に浸透させることができる。 The iontophoresis device and the electroporation device can be used independently, but may be used in combination. In this case, for example, first, a temporary hole is formed in the skin using an electroporation device, and then an active ingredient can be more efficiently penetrated into the living body from the formed hole by using the iontophoresis device. .
超音波導入装置もイオン導入装置と同様に使用することができる。また、超音波導入装置もイオン導入装置およびまたは電気穿孔装置と併用してもよい。この場合、イオン導入
装置と同様、まず電気穿孔装置を用いて皮膚に一時的な穴を形成した後、超音波導入装置を用いると、形成された穴から有効成分をより効率的に生体に浸透させることができる。
The ultrasonic introduction device can be used in the same manner as the ion introduction device. An ultrasonic introduction device may also be used in combination with an ion introduction device and / or an electroporation device. In this case, as with the iontophoresis device, a temporary hole is first formed in the skin using an electroporation device, and then the active ingredient penetrates the living body more efficiently from the formed hole when the ultrasonic introduction device is used. Can be made.
本実施形態では、電極パッド10が本体と分離した電気穿孔装置を説明したが、電気穿孔装置は電極パッド10が本体に一体的に設けられたハンディータイプであってもよいし、本体と本体に接続されたハンディータイプのプローブを備え、プローブに電極パッド10が一体的に設けられていてもよい。これらの場合、生体貼付け用選択透過膜100の表面に電極パッド10が設けられた部分を接触させて使用することによって、同様に有効成分を効率的に生体に浸透させることができる。
In the present embodiment, the electroporation apparatus in which the
(積層シート)
図4および図5は、本開示の実施形態による積層シートの一例を示す。図4に示すように、本開示の実施形態による生体貼付け用選択透過膜は、保護層が取り付けられた積層シートの形で提供されてもよい。図4に示す積層シート100Bは、セルロース膜100と、セルロース膜100の一方の主面上に配置された保護層101とを有する。セルロース膜100としては、上述の生体貼付け用選択透過膜100Aを適用することができ、セルロース膜100は、例えば、重量平均分子量が150000以上の再生セルロースで構成された膜であり得る。言うまでもないが、図4および図5は、積層シート100Bをあくまでも模式的に示し、現実の寸法が反映されているわけではない。例えば、セルロース膜100および保護層101の厚さは、図4および図5においては誇張されている。本開示の他の図面においても、説明の便宜のために、実際とは異なる寸法、形状でセルロース膜などを図示することがある。
(Laminated sheet)
4 and 5 show an example of a laminated sheet according to an embodiment of the present disclosure. As shown in FIG. 4, the permselective membrane for biological application according to an embodiment of the present disclosure may be provided in the form of a laminated sheet to which a protective layer is attached. A
この例では、セルロース膜100は、概ね円形状を有している。図4に示すセルロース膜100の直径は、例えば3mm程度であり得る。もちろん、セルロース膜100の形状は、図4に示す例に限定されず、楕円、多角形または不定形であり得る。また、セルロース膜100と保護層101とは、大きさが異なっていてもよい。
In this example, the
図5を参照する。セルロース膜100は、主面SfおよびSbを有し、ここでは、主面Sb側に保護層101が配置されている。保護層101は、例えば、ポリエチレン、ポリプロピレン、ポリエチレンテレフタレート、ナイロン、アクリル樹脂、ポリカーボネート、ポリ塩化ビニル、アクリロニトリル・ブタジエン・スチレン(ABS)樹脂、ポリウレタン、合成ゴム、セルロース、テフロン(登録商標)、アラミド、ポリイミドなどのシートもしくは不織布、または、シート状の金属、ガラスなどである。また、これらのシートまたは不織布の表面の全体または一部に化学的または物理的な表面処理が施されていてもよい。この例では、保護層101もセルロース膜100と同様に円形である。しかしながら、セルロース膜100および保護層101の形状が一致している必要はない。例えば、単一の保護層101上に複数のセルロース膜100が配置されることもある。なお、積層シート100B中の保護層101は、セルロース膜100の形状の維持のための支持体ではない。
Refer to FIG. The
図5に模式的に示すように、保護層101は、セルロース膜100の主面Sbから剥離可能に構成されている。セルロース膜100は、例えば23MPa以上の引張強さを有し、保護層101が剥離された状態においても形状を維持可能である。
As schematically shown in FIG. 5, the
ここで、図6~図11を参照しながら、本開示の積層シートの使用方法の例を説明する。 Here, an example of how to use the laminated sheet of the present disclosure will be described with reference to FIGS.
まず、上述の積層シート100Bを用意し、図6に示すように、セルロース膜100の主面SfおよびSbのうち、保護層101の配置されていない主面Sfを、積層シート1
00Bを貼りつけたい部分に対向させる。この例では、皮膚200(例えば顔の皮膚の一部)に、セルロース膜100の主面Sfを対向させる。
First, the above-mentioned
It is made to oppose the part which wants to stick 00B. In this example, the main surface Sf of the
このとき、セルロース膜100の主面Sf上または皮膚200上に、上述した有効成分を含む水溶液300を付与する。さらにクリーム302を配置してもよい。クリーム302は、例えば、油脂、アルコールまたは乳化剤などを含有し、上述した有効成分をさらに含んでいてもよい。
At this time, the
次に、セルロース膜100の主面Sfを皮膚200に対向させた状態で積層シート100Bを皮膚200に接触させることにより、図7に示すように、積層シート100Bを皮膚200に貼付する。さらに、図8に示すように、セルロース膜100の主面Sbから保護層101を剥離する。セルロース膜100から保護層101を剥離することにより、皮膚200上にセルロース膜100を残すことができる。
Next, the
セルロース膜100の主面Sf上に、他の保護層を設けておいてもよい。図9は、積層シートの他の例を示す。図9に示す積層シート100Cは、セルロース膜100の主面のうち、保護層101が配置された主面とは反対側の主面に、第2の保護層102を有する。保護層102を構成する材料は、保護層101と共通であってもよいし、異なっていてもよい。保護層102の大きさが、セルロース膜100または保護層101と異なっていても構わない。典型的には、この保護層102も、保護層101と同様にセルロース膜100から剥離可能である。保護層102の存在は、セルロース膜100のハンドリングをより容易にする。
Another protective layer may be provided on the main surface Sf of the
このような積層シート100Cを用いる場合、図10に示すように、まず、セルロース膜100から保護層101を剥離する。保護層101の除去により、セルロース膜100の主面Sbが露出される。その後、露出された主面Sbを皮膚200に対向させる。積層シート100Bの場合と同様に、このとき、セルロース膜100の主面Sb上または皮膚200上に、有効成分を含む水溶液300が付与される。さらにクリーム302が付与されてもよい。
When such a
次に、図11に示すように、セルロース膜100および第2の保護層102の積層シートを皮膚200に貼付する。その後、セルロース膜100の他方の主面、すなわち、主面Sbとは反対側の主面から、保護層102を剥離する。保護層102の剥離により、皮膚200上にセルロース膜100を残すことができる。
Next, as shown in FIG. 11, a laminated sheet of the
本開示の生体貼付け用選択透過膜は、前述したように、少なくとも一部が着色されていてもよい。図12は、着色されたセルロース膜100bを皮膚200に貼り付けた状態を模式的に示す。セルロース膜100bは、上述のセルロース膜100を染料、顔料などによって着色することにより得られた膜であり得る。上述した製造方法によれば、典型的には透明な再生セルロース膜が得られる。皮膚の色に近い色で着色されたセルロース膜100bを用いることにより、有効成分を作用させる部分が皮膚200のシミ、ホクロ、傷痕などである場合に、生体貼付け用選択透過膜これらを覆い、目立たなくすることが可能である。
As described above, at least a part of the permselective membrane for bioadhesion of the present disclosure may be colored. FIG. 12 schematically shows a state in which the
本開示の実施形態による生体貼付け用選択透過膜は、例えば傷痕の上に貼り付けられる場合には、外部からの刺激から皮膚を保護する保護シートとしても機能し得る。印刷などによって生体貼付け用選択透過膜に模様、色彩を施してもよい。 The permselective membrane for biological application according to an embodiment of the present disclosure can also function as a protective sheet that protects the skin from external irritation, for example, when applied to a scar. You may give a pattern and a color to the selective permeable membrane for biological sticking by printing etc.
(実施例)
以下、実施例により本開示の実施形態による選択透過する生体貼付け用選択透過膜をよ
り詳細に説明する。本開示の実施形態は、以下の実施例によって特定される形態に限定されない。
(Example)
Hereinafter, the permselective permselective membrane for selective permeation according to the embodiment of the present disclosure will be described in more detail with reference to examples. Embodiments of the present disclosure are not limited to the forms specified by the following examples.
(有効成分の浸透性評価)
(実施例1)
(選択透過する生体貼付け用選択透過膜の作製)
以下の手順により、生体貼付け用選択透過膜である再生セルロース膜を作製した。まず、純度が90%以上の、木材を原料とした漂白パルプ由来のセルロースを用意した。
(Evaluation of penetration of active ingredients)
(Example 1)
(Preparation of permselective membrane for selective biopermeation)
A regenerated cellulose membrane, which is a permselective membrane for biological application, was produced by the following procedure. First, a cellulose derived from bleached pulp made of wood and having a purity of 90% or more was prepared.
漂白パルプ由来のセルロースをイオン液体に溶解させることにより、セルロース溶液を調製した。イオン液体としては、1-エチル-3-メチルイミダゾリウムジエチルフォスフェイト(アルドリッチ社製、純度98%)を用いた。セルロース溶液は、ジメチルスルホキシドで希釈した。ギャップコーティングを適用して基板の表面にセルロース溶液を付与することにより、基板上に液膜を形成した。このとき、再生セルロース膜の厚みが1000nmになることを狙って、ギャップの大きさを調整した。 A cellulose solution was prepared by dissolving cellulose derived from bleached pulp in an ionic liquid. As the ionic liquid, 1-ethyl-3-methylimidazolium diethyl phosphate (manufactured by Aldrich, purity 98%) was used. The cellulose solution was diluted with dimethyl sulfoxide. A liquid film was formed on the substrate by applying a gap coating and applying a cellulose solution to the surface of the substrate. At this time, the size of the gap was adjusted aiming at the thickness of the regenerated cellulose film being 1000 nm.
液膜の形成後、セルロース溶液の液膜を70℃で1時間加熱し、その後20℃40-60%RH環境に置くことで高分子ゲルシートを得た。その後、高分子ゲルシートを洗浄することにより、高分子ゲルシートからイオン液体を除去した。その後、高分子ゲルシートを、テンション約0.1Nで乾燥させることにより、自立可能な、厚さ約930nmの再生セルロース膜を得た。再生セルロース膜は、概ね5cm×5cmの矩形形状を有していた。 After the formation of the liquid film, the liquid film of the cellulose solution was heated at 70 ° C. for 1 hour, and then placed in an environment of 20 ° C. and 40-60% RH to obtain a polymer gel sheet. Thereafter, the ionic liquid was removed from the polymer gel sheet by washing the polymer gel sheet. Thereafter, the polymer gel sheet was dried at a tension of about 0.1 N to obtain a regenerated cellulose film having a thickness of about 930 nm that can stand by itself. The regenerated cellulose membrane had a rectangular shape of approximately 5 cm × 5 cm.
再生セルロース膜の厚さは、ブルカー ナノ インコーポレイテッド製 触針式プロファイリングシステムDEKTAK(登録商標)を用いて、複数箇所測定し平均化することによって、ガラス板上に置いた再生セルロース膜の厚さを測定することで確認した。 The thickness of the regenerated cellulose film was measured by averaging several points using Bruker Nano Inc.'s stylus profiling system DEKTAK (registered trademark), and averaging the thickness of the regenerated cellulose film placed on the glass plate. Confirmed by measuring.
再生セルロース膜のセルロースの重量平均分子量をGPC(Gel Permeation Chromatography)-MALS(Multi Angle Light Scattering)法により測定した。測定には、島津製作所製の送液ユニットLC-20ADを用い、検出器としてWyatt Technology Corporation製、示差屈折率計Optilab rEXおよび多角度光散乱検出器DAWN
HELEOSを用いた。カラムとしては東ソー株式会社製のTSKgel α-Mを用い、溶媒には塩化リチウムが0.1M添加されたジメチルアセトアミドを用いた。カラム温度:23℃、流速:0.8mL/minの条件で測定を行った。再生セルロースの重量平均分子量は224000程度であった。
The weight average molecular weight of the cellulose in the regenerated cellulose membrane was measured by GPC (Gel Permeation Chromatography) -MALS (Multi Angle Light Scattering) method. For the measurement, a liquid feeding unit LC-20AD manufactured by Shimadzu Corporation was used. As a detector, a differential refractometer Optilab rEX and a multi-angle light scattering detector DAWN manufactured by Wyatt Technology Corporation were used.
HELEOS was used. The column used was TSKgel α-M manufactured by Tosoh Corporation, and the solvent used was dimethylacetamide to which 0.1 M lithium chloride was added. Measurement was performed under the conditions of column temperature: 23 ° C. and flow rate: 0.8 mL / min. The weight average molecular weight of the regenerated cellulose was about 224,000.
Park et al. “Cellulose crystallinity index: measurement techniques and their impact on interpreting cellulase performance”, Biotechnology for Biofuels 2010, 3:10において報告されている、13C-NMRを利用した方法に従って、再生セルロースの結晶化度を求めた。この方法によれば、固体13C-NMR測定により取得されたスペクトルにおける、87~93ppm付近のピークを結晶構造に由来するピークと扱い、かつ、80~87ppm付近のブロードなピークを非結晶構造に由来するピークと扱う。前者のピーク面積をX、後者のピーク面積をYとしたとき、下記の式(1)から結晶化度が決定される。なお、式(1)において、「×」は、乗算を表す。
(結晶化度)[%]=(X/(X+Y))×100 (1)
Park et al. "Cellulose crystallinity index: measurement techniques and their impact on interpreting cellulase performance", Biotechnology for Biofuels 2010, has been reported in 3:10, according to the method using 13 C-NMR, to determine the degree of crystallinity of regenerated cellulose. According to this method, in the spectrum obtained by solid state 13 C-NMR measurement, a peak in the vicinity of 87 to 93 ppm is treated as a peak derived from the crystal structure, and a broad peak in the vicinity of 80 to 87 ppm is converted into an amorphous structure. Treated as a derived peak. When the former peak area is X and the latter peak area is Y, the crystallinity is determined from the following equation (1). In Expression (1), “×” represents multiplication.
(Crystallinity) [%] = (X / (X + Y)) × 100 (1)
13C-NMRの測定には、Varian社製Unity Inova-400および
Doty Scientific, Inc.製の5mmのCP/MASプローブを使用し、CP/MAS法を用いた。測定条件は、MAS速度:10kHz、室温(25℃)、試料回転数:10kHz、観測幅:30.2kHz、観測中心:96ppm、観測周波数:100.574MHzであり、CPパルス(1H→13C)法で、観測核90°パルス:3.9μsec、1H励起パルス:3.8μsec、接触時間:2.0msec、待ち時間:10sec以上、積算回数:8,000回とした。この条件でCP法により測定したセルロースの固体13C-NMRスペクトルは、十分な緩和時間を設定したDD(Dipolar Decouple)法により測定した固体13C-NMRスペクトルとよく一致することを確認した。ここで、固体13C-NMRの基準物質はテトラメチルシラン(TMS)を用いた。算出された再生セルロースの結晶化度は、0%であった。
For 13 C-NMR measurement, Varian's Unity Inova-400 and Doty Scientific, Inc. were used. A CP / MAS method was used by using a 5 mm CP / MAS probe. The measurement conditions were MAS speed: 10 kHz, room temperature (25 ° C.), sample rotation speed: 10 kHz, observation width: 30.2 kHz, observation center: 96 ppm, observation frequency: 100.574 MHz, CP pulse (1H → 13 C) The observation nucleus 90 ° pulse: 3.9 μsec, 1H excitation pulse: 3.8 μsec, contact time: 2.0 msec, waiting time: 10 sec or more, integration number: 8,000 times. It was confirmed that the solid 13 C-NMR spectrum of the cellulose measured by the CP method under these conditions was in good agreement with the solid 13 C-NMR spectrum measured by the DD (Dipolar Decouple) method in which a sufficient relaxation time was set. Here, tetramethylsilane (TMS) was used as a reference material for solid state 13 C-NMR. The calculated recrystallization cellulose crystallinity was 0%.
細孔容積は、BELSORP-mini2(マイクロトラック・ベル株式会社)を用いて、窒素によるガス吸着法により測定し、BJH法で解析を行った。100nm以下の細孔容積は0.016cm3/gであった。また、作製した膜の吸水率は198%であった。 The pore volume was measured by a gas adsorption method using nitrogen using BELSORP-mini2 (Microtrack Bell Co., Ltd.) and analyzed by the BJH method. The pore volume of 100 nm or less was 0.016 cm 3 / g. Moreover, the water absorption of the produced film was 198%.
(水および有効成分の選択透過性評価)
再生セルロース膜の選択透過性については、浸透すると変色する紙を下地として、上に作製した再生セルロース膜を設置し、膜上から水(分子量:18)、プロパノール(分子量:60)、オクタノール(分子量:130)、デカン(分子量:142)、オレイン酸(分子量:282)をそれぞれ滴下した。下地の変色評価は、周りからの液の回り込みがないことを確認しながら、実施した。
(Evaluation of selective permeability of water and active ingredients)
Regarding the selective permeability of the regenerated cellulose membrane, the regenerated cellulose membrane prepared above is placed on the paper that changes color when infiltrated, and water (molecular weight: 18), propanol (molecular weight: 60), octanol (molecular weight) are placed on the membrane. : 130), decane (molecular weight: 142), and oleic acid (molecular weight: 282) were added dropwise. The discoloration evaluation of the base was performed while confirming that there was no wraparound of the liquid from the surroundings.
水を滴下した場合は10秒以内に下地は変色し、水が再生セルロース膜を透過したことを確認できたが、プロパノール、オクタノール、デカン、オレイン酸を滴下した場合は、5分経過しても下地の変色は見られず、プロパノール、オクタノール、デカン、オレイン酸は再生セルロース膜を透過しなかった。 When water was dripped, the base color changed within 10 seconds, and it was confirmed that water permeated the regenerated cellulose membrane. However, when propanol, octanol, decane, and oleic acid were dripped, even after 5 minutes had passed. No discoloration of the ground was observed, and propanol, octanol, decane and oleic acid did not permeate the regenerated cellulose membrane.
次に、分子量2000-4000の蛍光標識化したヒアルロン酸((株)PGリサーチ製Fluoresceinamine labeled Sodium Hyaluronate(3K2))の0.1重量%水溶液を、下地上に設置した再生セルロース膜の上から滴下した。滴下後30秒後再生セルロース膜を取り外し、下地に水の透過による変色の有無と、蛍光顕微鏡により、蛍光化したヒアルロン酸が検出されるかを確認した。蛍光顕微鏡は、キーエンス社製の蛍光顕微鏡を用いた。励起波長470nm、吸収波長525nm、露光時間1/200sで行った。水の透過による下地の変色を確認した。蛍光顕微鏡によるヒアルロン酸は検出限界以下であり、再生セルロース膜が水のみを透過していることを確認した。同様の方法で、分子量5000-10000の蛍光標識化したヒアルロン酸((株)PGリサーチ製 Fluoresceinamine labeled Sodium Hyaluronate(U2))についても、評価を行い、水の透過による下地の変色は確認できたが、蛍光顕微鏡によるヒアルロン酸は検出限界以下で有り、再生セルロース膜が水のみを透過していることを確認した。 Next, a 0.1% by weight aqueous solution of fluorescently labeled hyaluronic acid having a molecular weight of 2000 to 4000 (Fluoresceinamine labeled Sodium Hyaluronate (3K2) manufactured by PG Research Co., Ltd.) was dropped from above the regenerated cellulose membrane placed on the substrate. did. 30 seconds after the dropping, the regenerated cellulose membrane was removed, and it was confirmed whether or not the fluorescent hyaluronic acid was detected with a fluorescence microscope by the presence or absence of discoloration due to permeation of water on the base. A fluorescence microscope manufactured by Keyence Corporation was used as the fluorescence microscope. The excitation wavelength was 470 nm, the absorption wavelength was 525 nm, and the exposure time was 1/200 s. Discoloration of the groundwork due to water permeation was confirmed. Hyaluronic acid by a fluorescence microscope was below the detection limit, and it was confirmed that the regenerated cellulose membrane permeated only water. In the same manner, fluorescently labeled hyaluronic acid having a molecular weight of 5000 to 10000 (Fluoresceinamine labeled Sodium Hyaluronate (U2) manufactured by PG Research Co., Ltd.) was also evaluated. It was confirmed that hyaluronic acid by a fluorescence microscope was below the detection limit and that the regenerated cellulose membrane permeated only water.
次に、アスコルビン酸水溶液を下地上に設置した再生セルロース膜の上から滴下した。滴下後30秒後選択透過膜を取り外し、下地に水の透過による変色の有無と、下地を抽出し、吸光分析法によりアスコルビン酸が検出されるかを確認した。吸光分析は島津製作所製 UV1600により行い、266nmの吸収について検量線を用いて評価を行った。水の透過による下地の変色は確認できたが、吸光分析法によるアスコルビン酸は検出限界以下で有り、再生セルロース膜が水のみを透過していることを確認した。 Next, an ascorbic acid aqueous solution was dropped from above the regenerated cellulose membrane placed on the base. After 30 seconds from the dropping, the selective permeable membrane was removed, the presence or absence of discoloration due to the permeation of water on the base, the base was extracted, and it was confirmed whether ascorbic acid was detected by absorption spectrometry. Absorption analysis was performed by Shimadzu UV1600, and the absorption at 266 nm was evaluated using a calibration curve. Although discoloration of the groundwork due to water permeation was confirmed, it was confirmed that ascorbic acid by absorption spectrometry was below the detection limit, and that the regenerated cellulose membrane permeated only water.
(有効成分の肌への浸透性評価:機器使用時)
以下の手順で、機器を用いた場合の有効成分の肌への浸透性評価を実施した。
(Evaluation of penetration of active ingredients into the skin: when using the device)
The following procedure evaluated the penetration of the active ingredient into the skin when the device was used.
蛍光標識したヒアルロン酸水溶液を前腕内側の肌上に塗布する。その後、再生セルロース膜を肌上に配置し、電極の施術面側に絶縁体を設けたエレクトロポレーション電極を用いて、37V、1kHz、Duly50で3秒間穿孔形成を行う。その後速やかに、イオン導入を6秒実施する。施術3分後に施術箇所の角質層をテープストリップ法によりサンプリングし、7層目中の皮膚面積に対するヒアルロン酸による発光面積比率をレーザ顕微鏡で評価した。分子量2000-4000のヒアルロン酸の結果を図13に、分子量5000-10000のヒアルロン酸の結果を図14に示す。 ¡Apply fluorescently labeled hyaluronic acid aqueous solution to the skin inside the forearm. Thereafter, a regenerated cellulose film is placed on the skin, and perforation is performed for 3 seconds at 37 V, 1 kHz, Duly 50 using an electroporation electrode in which an insulator is provided on the treatment surface side of the electrode. Immediately thereafter, ion introduction is performed for 6 seconds. Three minutes after the treatment, the stratum corneum at the treatment site was sampled by a tape strip method, and the ratio of the light emission area by hyaluronic acid to the skin area in the seventh layer was evaluated by a laser microscope. The results for hyaluronic acid with a molecular weight of 2000-4000 are shown in FIG. 13, and the results for hyaluronic acid with a molecular weight of 5000-10000 are shown in FIG.
(有効成分の肌への浸透性評価:シートのみ)
以下の手順で、有効成分の肌への浸透性評価を実施した。
(Evaluation of penetration of active ingredients into skin: sheet only)
The following procedure evaluated the penetration of active ingredients into the skin.
ビタミンC(アスコルビン酸ナトリウム)水溶液を肌に滴下後、再生セルロース膜を設置し、30分静置した。その後、テープストリッピング用のテープを貼付け、角質を2枚除去した。同じ箇所で3~12枚目(計10枚)の角質をテープストリップで剥がし、測定試料とした。測定試料は、水4mLを加え3分超音波処理を行い抽出した液を、島津製作所社製LC-Vp10の高速液体クロマトグラフを用いて評価を行った。結果を図15に示す。 Vitamin C (sodium ascorbate) aqueous solution was dropped on the skin, and then a regenerated cellulose membrane was placed and allowed to stand for 30 minutes. Thereafter, a tape for tape stripping was affixed, and two keratins were removed. The third to twelfth (a total of ten) keratins were peeled off with a tape strip at the same location, and used as a measurement sample. For the measurement sample, 4 mL of water was added and subjected to ultrasonic treatment for 3 minutes, and the extracted liquid was evaluated using an LC-Vp10 high performance liquid chromatograph manufactured by Shimadzu Corporation. The results are shown in FIG.
(実施例2)
厚みが300nmとなることを狙ってギャップコーティングの条件を調整した以外は、実施例1と同様にして、実施例2に係る再生セルロース膜を作製した。実施例2に係る再生セルロース膜の厚みは320nmであった。また、100nm以下の細孔容積は0.047cm3/gであった。実施例2に係る再生セルロース膜の厚み、および細孔体積は、実施例1と同様にして測定した。実施例2に係わる再生セルロース膜を用いて、下地上に実施例2に係わる再生セルロース膜を設置し、その上から有効成分として、分子量2000-4000および分子量5000-10000の蛍光標識したヒアルロン酸が含有した水溶液を滴下し30秒静置したところ、水の透過による下地の変色を確認した。蛍光顕微鏡による評価では、何れのヒアルロン酸も検出限界以下であり、実施例2に係わる再生セルロース膜が水のみを透過していることを確認した。
(Example 2)
A regenerated cellulose membrane according to Example 2 was produced in the same manner as in Example 1 except that the condition of gap coating was adjusted aiming at a thickness of 300 nm. The thickness of the regenerated cellulose film according to Example 2 was 320 nm. The pore volume of 100 nm or less was 0.047 cm 3 / g. The thickness and pore volume of the regenerated cellulose membrane according to Example 2 were measured in the same manner as in Example 1. Using the regenerated cellulose membrane according to Example 2, the regenerated cellulose membrane according to Example 2 was placed on the base, and from that, fluorescently labeled hyaluronic acid having a molecular weight of 2000-4000 and a molecular weight of 5000-10000 was used as an active ingredient. When the contained aqueous solution was dropped and allowed to stand for 30 seconds, discoloration of the foundation due to water permeation was confirmed. In the evaluation by the fluorescence microscope, it was confirmed that any hyaluronic acid was below the detection limit, and the regenerated cellulose membrane according to Example 2 permeated only water.
(比較例1)
機器使用時の有効成分の肌への浸透性評価において、蛍光標識したヒアルロン酸(分子量2000-4000、および分子量5000-10000)水溶液を上腕内側の肌上に塗布した後、膜を貼り付けずに穿孔形成を行った以外は実施例1と同様に評価を行った。結果を図13および図14に示す。
(Comparative Example 1)
In the evaluation of the penetration of active ingredients into the skin when using the device, a fluorescently labeled aqueous solution of hyaluronic acid (molecular weight 2000-4000 and molecular weight 5000-10000) was applied on the skin on the inner side of the upper arm, and the film was not attached. Evaluation was performed in the same manner as in Example 1 except that perforation formation was performed. The results are shown in FIG. 13 and FIG.
また、シートのみの有効成分の肌への浸透性評価において、膜を貼り付けなかった以外は実施例1と同様に評価を行った。結果を図13および図14に示す。 Further, in the evaluation of the penetration of the active ingredient of only the sheet into the skin, the evaluation was performed in the same manner as in Example 1 except that no film was attached. The results are shown in FIG. 13 and FIG.
(比較例2)
重量平均分子量250,000のポリ乳酸をクロロホルムに溶解することにより、ポリ乳酸溶液を調製した。重量平均分子量500程度のポリビニルアルコール膜が予め形成された基板上に、スピンコーティングによってポリ乳酸溶液を付与した後、溶媒であるクロロホルムを気化させた。その後、水への浸漬によりポリビニルアルコールを除去し、比較例2のポリ乳酸膜を作製した。得られたポリ乳酸膜の厚さは、約960nmであった。
(Comparative Example 2)
A polylactic acid solution was prepared by dissolving polylactic acid having a weight average molecular weight of 250,000 in chloroform. After a polylactic acid solution was applied by spin coating on a substrate on which a polyvinyl alcohol film having a weight average molecular weight of about 500 was previously formed, chloroform as a solvent was vaporized. Thereafter, polyvinyl alcohol was removed by immersion in water, and a polylactic acid film of Comparative Example 2 was produced. The thickness of the obtained polylactic acid film was about 960 nm.
下地上にポリ乳酸膜を設置し、その上から蛍光標識したヒアルロン酸(分子量2000-4000、分子量5000-10000)を含有した水溶液を滴下し30秒設置したが
、下地に水の浸透は確認できなかった。また、蛍光顕微鏡観察において、何れのヒアルロン酸も検出されなかった。
A polylactic acid film was placed on the ground, and an aqueous solution containing fluorescently labeled hyaluronic acid (molecular weight 2000-4000, molecular weight 5000-10000) was dropped on it and placed for 30 seconds. There wasn't. Also, no hyaluronic acid was detected in the fluorescence microscope.
有効成分の肌への浸透性評価において、選択透過膜の変わりにポリ乳酸膜を使用した以外は実施例1同様に評価を行った。結果を図13および図14に示す。 In the evaluation of the penetration of active ingredients into the skin, evaluation was performed in the same manner as in Example 1 except that a polylactic acid membrane was used instead of the permselective membrane. The results are shown in FIG. 13 and FIG.
(比較例3)
厚さ23μmのポリエチレンテレフタレート(PET)シートを用いて、下地にPETシートを設置し、その上から有効成分として、分子量2000-4000および分子量5000-10000の蛍光標識したヒアルロン酸が含有した水溶液を滴下し30秒静置したが、下地の変色はなく水の浸透は確認できなかった。また、蛍光顕微鏡観察において、何れのヒアルロン酸も検出されなかった。PETシートの吸水率は、0.4%であった。
(Comparative Example 3)
Using a polyethylene terephthalate (PET) sheet with a thickness of 23 μm, a PET sheet was placed on the base, and an aqueous solution containing fluorescently labeled hyaluronic acid having a molecular weight of 2000-4000 and a molecular weight of 5000-10000 was dropped from the PET sheet as an active ingredient. However, it was allowed to stand for 30 seconds, but the base material was not discolored and water penetration could not be confirmed. Also, no hyaluronic acid was detected in the fluorescence microscope. The water absorption rate of the PET sheet was 0.4%.
有効成分の肌への浸透性評価において、選択透過膜の変わりにPETシートを使用して、分子量2000-4000の蛍光標識したヒアルロン酸を用いた以外は実施例1同様に評価を行った。結果を図13に示す。 In the evaluation of the penetration of the active ingredient into the skin, evaluation was performed in the same manner as in Example 1 except that a PET sheet was used instead of the permselective membrane and fluorescently labeled hyaluronic acid having a molecular weight of 2000 to 4000 was used. The results are shown in FIG.
(比較例4)
厚さ約20μmの市販のセロハン(再生セルロース)を用いて、下地上にセロハンを設置し、その上から有効成分として、分子量2000-4000および分子量5000-10000の蛍光標識したヒアルロン酸が含有した水溶液を滴下し30秒静置したが、下地の変色はなく水の浸透は確認できなかった。また、蛍光顕微鏡観察において、何れのヒアルロン酸も検出されなかった。セロハンの結晶化度は21%であった。
(Comparative Example 4)
A commercially available cellophane (regenerated cellulose) having a thickness of about 20 μm is used. An aqueous solution containing cellophane on a base and containing fluorescently labeled hyaluronic acid having a molecular weight of 2000-4000 and a molecular weight of 5000-10000 as an active ingredient from above. The solution was dropped and allowed to stand for 30 seconds, but there was no discoloration of the foundation and water penetration could not be confirmed. Also, no hyaluronic acid was detected in the fluorescence microscope. The crystallinity of cellophane was 21%.
有効成分の浸透性評価において、選択透過膜の変わりにセロハンを使用し、分子量2000-4000の蛍光標識したヒアルロン酸を用いた以外は実施例1同様に評価を行った。結果を図13に示す。 In the evaluation of the permeability of the active ingredient, evaluation was carried out in the same manner as in Example 1 except that cellophane was used instead of the permselective membrane and fluorescently labeled hyaluronic acid having a molecular weight of 2000 to 4000 was used. The results are shown in FIG.
(比較例5)
厚さ約150μmのろ紙(天然セルロース)を用いて、下地上にろ紙を設置し、その上から有効成分として、分子量2000-4000および分子量5000-10000の蛍光標識したヒアルロン酸が含有した水溶液を滴下し30秒静置したところ、水の浸透と有効成分双方の浸透を確認した。
(Comparative Example 5)
Using filter paper (natural cellulose) with a thickness of about 150 μm, place the filter paper on the base, and drop an aqueous solution containing hyaluronic acid with a molecular weight of 2000-4000 and a molecular weight of 5000-10000 as the active ingredient. After standing for 30 seconds, the penetration of water and the penetration of both active ingredients were confirmed.
有効成分の浸透性評価において、選択透過膜の変わりにろ紙を使用し、分子量2000-4000の蛍光標識したヒアルロン酸を用いた以外は実施例1同様に評価を行った。結果を図13に示す。 In the evaluation of the permeability of the active ingredient, evaluation was performed in the same manner as in Example 1 except that filter paper was used instead of the permselective membrane and fluorescently labeled hyaluronic acid having a molecular weight of 2000 to 4000 was used. The results are shown in FIG.
(比較例6)
市販のキトサンを含むナノファイバーシート(マジックフェイシャル、株式会社エコライフ製)を用いて、下地上にナノファイバーシートを設置し、その上から有効成分として、分子量2000-4000および5000-10000の蛍光標識したヒアルロン酸が含有した水溶液を滴下し30秒静置したところ、水の浸透と有効成分双方の浸透を確認した。
(Comparative Example 6)
Using a commercially available nanofiber sheet containing Chitosan (Magic Facial, manufactured by Ecolife Co., Ltd.), a nanofiber sheet is placed on the base, and fluorescent labels with molecular weights of 2000-4000 and 5000-10000 are used as active ingredients from above. When an aqueous solution containing the hyaluronic acid was dropped and allowed to stand for 30 seconds, penetration of water and penetration of both active ingredients were confirmed.
有効成分の浸透性評価において、選択透過膜の変わりにナノファイバーシートを使用し、分子量2000-4000の蛍光標識したヒアルロン酸を用いた以外は実施例1同様に評価を行った。結果を図13に示す。 In the evaluation of the permeability of the active ingredient, evaluation was performed in the same manner as in Example 1 except that a nanofiber sheet was used instead of the permselective membrane and fluorescently labeled hyaluronic acid having a molecular weight of 2000 to 4000 was used. The results are shown in FIG.
(比較例7)
純度が90%以上の、木材を原料とした漂白パルプ由来のセルロースを用意した。漂白パルプ由来のセルロースをイオン液体に溶解させることにより、セルロース溶液を調製した。イオン液体としては、1-エチル-3-メチルイミダゾリウムジエチルフォスフェイト(アルドリッチ社製、純度98%)を用いた。セルロース溶液は、ジメチルスルホキシドで希釈した。ギャップコーティングを適用して基板の表面にセルロース溶液を付与することにより、基板上に液膜を形成した。このとき、比較例7に係る生体貼付用膜の厚みが300nmとなることを狙ってギャップコーティングにおけるギャップの大きさを調整した。液膜の形成後、20℃40-60%RH環境に置くことで高分子ゲルシートを得た。その後、高分子ゲルシートを洗浄することにより、高分子ゲルシートからイオン液体を除去した。その後、高分子ゲルシートを、自然乾燥させることにより、自立可能な、厚さ約300nmの比較例7に係わる再生セルロース膜を得た。比較例7に係る生体貼付用膜において、100nm以下の細孔径を有する細孔の細孔容積は0.44cm3/gであった
。
(Comparative Example 7)
A cellulose derived from bleached pulp made of wood and having a purity of 90% or more was prepared. A cellulose solution was prepared by dissolving cellulose derived from bleached pulp in an ionic liquid. As the ionic liquid, 1-ethyl-3-methylimidazolium diethyl phosphate (manufactured by Aldrich, purity 98%) was used. The cellulose solution was diluted with dimethyl sulfoxide. A liquid film was formed on the substrate by applying a gap coating and applying a cellulose solution to the surface of the substrate. At this time, the size of the gap in the gap coating was adjusted aiming at the thickness of the bioadhesive film according to Comparative Example 7 being 300 nm. After the formation of the liquid film, the polymer gel sheet was obtained by placing in a 20-60 ° C. 40-60% RH environment. Thereafter, the ionic liquid was removed from the polymer gel sheet by washing the polymer gel sheet. Thereafter, the polymer gel sheet was naturally dried to obtain a regenerated cellulose membrane according to Comparative Example 7 having a thickness of about 300 nm, which can stand by itself. In the biological patch membrane according to Comparative Example 7, the pore volume of pores having a pore diameter of 100 nm or less was 0.44 cm 3 / g.
比較例7に係わる再生セルロース膜を用いて、下地上に比較例7に係わる再生セルロース膜を設置し、その上から有効成分として、分子量2000-4000および分子量5000-10000の蛍光標識したヒアルロン酸が含有した水溶液を滴下し30秒静置したところ、水の浸透と有効成分双方の浸透を確認した。 Using the regenerated cellulose membrane according to Comparative Example 7, the regenerated cellulose membrane according to Comparative Example 7 was placed on the substrate, and from that, fluorescently labeled hyaluronic acid having a molecular weight of 2000-4000 and a molecular weight of 5000-10000 was used as an active ingredient. When the contained aqueous solution was dropped and allowed to stand for 30 seconds, penetration of water and penetration of both active ingredients were confirmed.
図13に、実施例1および比較例1-6の分子量2000-4000のヒアルロン酸の浸透性評価結果を示す。図13より、比較例1-6と比較して、実施例1ではヒアルロン酸を肌中に浸透させる能力が高いことが分かる。特に比較例2との比較により、同じ程度の厚さの膜であっても実施例1ではヒアルロン酸を浸透できることが分かる。 FIG. 13 shows the results of evaluating the permeability of hyaluronic acid having a molecular weight of 2000 to 4000 in Example 1 and Comparative Example 1-6. FIG. 13 shows that Example 1 has a higher ability to penetrate hyaluronic acid into the skin as compared with Comparative Example 1-6. In particular, by comparison with Comparative Example 2, it can be seen that hyaluronic acid can be penetrated in Example 1 even if the film has the same thickness.
図14に、実施例1および比較例1-2の分子量5000-10000のヒアルロン酸の浸透性評価結果を示す。図14より、分子量が5000-10000の場合においても、比較例1-2と比較して、実施例1ではヒアルロン酸を肌中に浸透させる能力が高いことが分かる。 FIG. 14 shows the results of evaluating the permeability of hyaluronic acid having a molecular weight of 5000 to 10,000 in Example 1 and Comparative Example 1-2. FIG. 14 shows that even when the molecular weight is 5000-10000, Example 1 has a higher ability to penetrate hyaluronic acid into the skin than Comparative Example 1-2.
図15に、実施例1および比較例1のビタミンCの浸透性評価結果を示す。図15より、比較例2と比較して、実施例1ではビタミンCの肌への浸透性が高いことが分かる。 FIG. 15 shows the results of evaluating vitamin C permeability of Example 1 and Comparative Example 1. From FIG. 15, it can be seen that in Example 1, the permeability of vitamin C to the skin is higher than in Comparative Example 2.
(生体貼付け用選択透過膜の肌への密着性評価)
(実施例3)
セルロース溶液中のセルロース濃度と、ギャップの大きさとを調整することにより、ねらい厚さを100nm、200nm、500nm、1300nmとして、実施例1と同様の方法で実施例3のセルロース膜を作製した。各ねらい厚さに対する、得られたセルロース膜の厚さは、それぞれ、約90nm、約220nm、約510nm、約1340nmであった。
(Evaluation of adhesion to skin of selective permeable membrane for biological application)
(Example 3)
By adjusting the cellulose concentration in the cellulose solution and the size of the gap, the cellulose film of Example 3 was produced in the same manner as in Example 1 with a target thickness of 100 nm, 200 nm, 500 nm, and 1300 nm. The resulting cellulose membrane thicknesses for each target thickness were about 90 nm, about 220 nm, about 510 nm, and about 1340 nm, respectively.
(比較例8)
セルロース溶液中のセルロース濃度と、ギャップの大きさとを調整することにより、ねらい厚さを3000nm、5000nmとして、実施例1と同様の方法で比較例7のセルロース膜を作製した。各ねらい厚さに対する、得られたセルロース膜の厚さは、それぞれ、約2700nm、約5000nmであった。
(Comparative Example 8)
By adjusting the cellulose concentration in the cellulose solution and the size of the gap, the target thickness was set to 3000 nm and 5000 nm, and a cellulose film of Comparative Example 7 was produced in the same manner as in Example 1. The thickness of the obtained cellulose membrane for each target thickness was about 2700 nm and about 5000 nm, respectively.
以下の手法により、セルロース膜を皮膚に貼り付けたときの密着性を評価した。まず、上腕内側の皮膚上に市販の化粧水を少量付与し、その上にサンプル(セルロース膜)を貼付した。その状態で5h経過後、サンプルが皮膚上から脱落したか否かを調べた。 The adhesion when the cellulose film was attached to the skin was evaluated by the following method. First, a small amount of a commercially available lotion was applied to the skin on the inner side of the upper arm, and a sample (cellulose membrane) was stuck thereon. After 5 hours in that state, it was examined whether the sample had fallen off from the skin.
図16は、実施例1、3および比較例4、8のサンプルに関する評価結果を示すグラフである。図16に示すグラフの縦軸は、サンプルが貼付された人(合計5人)のうち、皮膚上のサンプルが脱落した人の割合を示す。 FIG. 16 is a graph showing the evaluation results regarding the samples of Examples 1 and 3 and Comparative Examples 4 and 8. The vertical axis | shaft of the graph shown in FIG. 16 shows the ratio of the person from whom the sample on skin fell out among the persons (total 5 persons) to whom the sample was affixed.
図16より、生体貼付け用選択透過膜である再生セルロースは、厚さを1300nm程度以下とすることにより、皮膚上から脱落しにくい、換言すれば、皮膚に対する密着性の良い薄膜を提供できることがわかる。厚さ1300nm以下の生体貼付け用選択透過膜は、粘着剤なしで肌に長時間接着させることができるため、より美容効果を持続させることができる。 From FIG. 16, it can be seen that the regenerated cellulose, which is a permselective membrane for attaching to a living body, can be provided with a thin film having a good adhesion to the skin, in other words, it is difficult to drop off from the skin when the thickness is about 1300 nm or less. . Since the permselective membrane with a thickness of 1300 nm or less can be adhered to the skin for a long time without an adhesive, the cosmetic effect can be further maintained.
本開示の実施形態による生体貼付け用選択透過膜は、接着剤なしに皮膚に貼付可能であり、更に有効成分を含む水溶液の水を選択的に透過させることから、皮膚上の有効成分濃度を上げることで、美容効果を高めることが可能である。更に、穿孔形成装置および/またはイオン導入装置および/または超音波導入を併せて行うことで、より高い美容効果が得られる。 The permselective membrane for biological application according to an embodiment of the present disclosure can be applied to the skin without an adhesive, and further selectively permeates water in an aqueous solution containing the active ingredient, thus increasing the active ingredient concentration on the skin. Thus, it is possible to enhance the beauty effect. Furthermore, a higher cosmetic effect can be obtained by performing the perforation forming device and / or the iontophoresis device and / or the ultrasonic wave introduction together.
本開示の生体貼付け用選択透過膜は、例えば、美容または医療を目的とした肌ケアフィルムなどとして利用できる。 The permselective membrane for biological application of the present disclosure can be used as, for example, a skin care film for beauty or medical purposes.
10 電極
21a、21b 絶縁層
23 第1電極
24 第2電極
25a、25b 絶縁層
30 生体
40 水溶液
60 電気穿孔装置本体
70 イオン導入装置
70a ヘッド
70b グリップ
100、100A 生体貼付け用選択透過膜
100B、100C 積層シート
101 保護層
102 第2の保護層
200 皮膚
300 水溶液
302 クリーム
DESCRIPTION OF
Claims (11)
イオン導入装置、電気穿孔装置および超音波導入装置からなる群から選択される少なくとも1つと、
を備えた経皮吸収キット。 The permselective membrane for biological application according to any one of claims 1 to 6,
At least one selected from the group consisting of an iontophoresis device, an electroporation device and an ultrasound introduction device;
A transdermal absorption kit comprising:
前記水溶液の少なくとも一部を覆うように、請求項1から6のいずれかに記載の生体貼付け用選択透過膜を皮膚に貼付するステップと、
前記有効成分を前記皮膚から内部へ浸透させるステップと
を含む美容方法。 Placing an aqueous solution containing an active ingredient on the skin;
Applying the permselective membrane for biological application according to any one of claims 1 to 6 to the skin so as to cover at least a part of the aqueous solution;
A cosmetic method comprising the step of allowing the active ingredient to penetrate from the skin into the interior.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201980020261.0A CN111885992B (en) | 2018-05-17 | 2019-02-07 | Selective permeable membranes, transdermal absorption kits and beauty methods for biologic patching |
| JP2020518970A JP7170285B2 (en) | 2018-05-17 | 2019-02-07 | Selectively permeable membrane for application to living body, transdermal absorption kit, and cosmetic method |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018-095408 | 2018-05-17 | ||
| JP2018095408 | 2018-05-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2019220697A1 true WO2019220697A1 (en) | 2019-11-21 |
Family
ID=68540134
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/JP2019/004361 Ceased WO2019220697A1 (en) | 2018-05-17 | 2019-02-07 | Selectively permeable film for application to living body, percutaneous absorption kit, and aesthetic method |
Country Status (3)
| Country | Link |
|---|---|
| JP (1) | JP7170285B2 (en) |
| CN (1) | CN111885992B (en) |
| WO (1) | WO2019220697A1 (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021112203A1 (en) * | 2019-12-06 | 2021-06-10 | 凸版印刷株式会社 | Skin attachment-use film, and transfer sheet |
| CN115702337A (en) * | 2020-07-02 | 2023-02-14 | 松下知识产权经营株式会社 | Functional component and chemical substance sensor having the functional component |
| EP4180117A1 (en) * | 2021-11-16 | 2023-05-17 | Sartorius Stedim Biotech GmbH | Membrane for microbiological analysis |
| US20230168217A1 (en) * | 2020-04-27 | 2023-06-01 | Fepod Oy Ltd | Test strip for the detection of neutral analytes in a sample |
Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5889627A (en) * | 1981-11-25 | 1983-05-28 | Asahi Chem Ind Co Ltd | Finely porous regenerated cellulose membrane |
| JP2004202086A (en) * | 2002-12-26 | 2004-07-22 | Teikoku Seiyaku Co Ltd | Medicator for electroporation, and system and method of medication for electroporation |
| JP2007195607A (en) * | 2006-01-24 | 2007-08-09 | Transcutaneous Technologies Inc | Drug delivery method, and drug delivery device |
| JP2010202577A (en) * | 2009-03-03 | 2010-09-16 | Toppan Forms Co Ltd | Medicine for iontophoresis, and device for iontophoresis |
| JP2010253199A (en) * | 2009-04-28 | 2010-11-11 | Toppan Forms Co Ltd | Electroporation device |
| JP2012025704A (en) * | 2010-07-26 | 2012-02-09 | Sepa Sigma Inc | Porous multilayered regenerated cellulose flat film for cosmetic sheet |
| JP2014207987A (en) * | 2013-03-28 | 2014-11-06 | 株式会社 東北テクノアーチ | Biological tissue sticking kit and biological tissue sticking patch |
| JP2014227389A (en) * | 2013-05-24 | 2014-12-08 | ロレアル | Self-supporting cosmetic sheet |
| JP2015193604A (en) * | 2014-03-18 | 2015-11-05 | パナソニックIpマネジメント株式会社 | SKIN Attaching Sheet Preparation Method, Beauty Method, and Skin Attaching Sheet |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1905433A1 (en) * | 2005-07-15 | 2008-04-02 | Transcu Ltd. | Percutaneous absorption patch with application position indicating function, and iontophoresis device |
| CN101545150B (en) * | 2009-04-30 | 2011-01-05 | 郑睿敏 | Method for manufacturing modal fiber |
| RS54173B1 (en) * | 2010-12-14 | 2015-12-31 | Acino Ag | TRANSDERMAL THERAPY SYSTEM FOR ACTIVE SUBSTANCE |
-
2019
- 2019-02-07 CN CN201980020261.0A patent/CN111885992B/en active Active
- 2019-02-07 JP JP2020518970A patent/JP7170285B2/en active Active
- 2019-02-07 WO PCT/JP2019/004361 patent/WO2019220697A1/en not_active Ceased
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5889627A (en) * | 1981-11-25 | 1983-05-28 | Asahi Chem Ind Co Ltd | Finely porous regenerated cellulose membrane |
| JP2004202086A (en) * | 2002-12-26 | 2004-07-22 | Teikoku Seiyaku Co Ltd | Medicator for electroporation, and system and method of medication for electroporation |
| JP2007195607A (en) * | 2006-01-24 | 2007-08-09 | Transcutaneous Technologies Inc | Drug delivery method, and drug delivery device |
| JP2010202577A (en) * | 2009-03-03 | 2010-09-16 | Toppan Forms Co Ltd | Medicine for iontophoresis, and device for iontophoresis |
| JP2010253199A (en) * | 2009-04-28 | 2010-11-11 | Toppan Forms Co Ltd | Electroporation device |
| JP2012025704A (en) * | 2010-07-26 | 2012-02-09 | Sepa Sigma Inc | Porous multilayered regenerated cellulose flat film for cosmetic sheet |
| JP2014207987A (en) * | 2013-03-28 | 2014-11-06 | 株式会社 東北テクノアーチ | Biological tissue sticking kit and biological tissue sticking patch |
| JP2014227389A (en) * | 2013-05-24 | 2014-12-08 | ロレアル | Self-supporting cosmetic sheet |
| JP2015193604A (en) * | 2014-03-18 | 2015-11-05 | パナソニックIpマネジメント株式会社 | SKIN Attaching Sheet Preparation Method, Beauty Method, and Skin Attaching Sheet |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021112203A1 (en) * | 2019-12-06 | 2021-06-10 | 凸版印刷株式会社 | Skin attachment-use film, and transfer sheet |
| US20230168217A1 (en) * | 2020-04-27 | 2023-06-01 | Fepod Oy Ltd | Test strip for the detection of neutral analytes in a sample |
| CN115702337A (en) * | 2020-07-02 | 2023-02-14 | 松下知识产权经营株式会社 | Functional component and chemical substance sensor having the functional component |
| EP4180117A1 (en) * | 2021-11-16 | 2023-05-17 | Sartorius Stedim Biotech GmbH | Membrane for microbiological analysis |
| WO2023088888A1 (en) * | 2021-11-16 | 2023-05-25 | Sartorius Stedim Biotech Gbmh | Membrane for microbiological analysis |
Also Published As
| Publication number | Publication date |
|---|---|
| CN111885992A (en) | 2020-11-03 |
| JPWO2019220697A1 (en) | 2021-06-17 |
| CN111885992B (en) | 2023-12-08 |
| JP7170285B2 (en) | 2022-11-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20220296721A1 (en) | Membrane for sticking to living organism, and method for producing same | |
| JP7170285B2 (en) | Selectively permeable membrane for application to living body, transdermal absorption kit, and cosmetic method | |
| JP7253714B2 (en) | Adhesive film for living body and cosmetic method of sticking the film for living body | |
| US20140194379A1 (en) | Methods for the production of chitin nanofibers and uses thereof | |
| WO2014058066A1 (en) | Cosmetic method | |
| JP2013184970A (en) | Thin film transfer sheet, method for production thereof, and method for transferring to thin layer adherend | |
| JP2015110294A (en) | Sheet for adhesion | |
| US12194161B2 (en) | Living body-adhesive sheet | |
| JP7170231B2 (en) | Adhesive film for living body, laminate, and cosmetic method | |
| CN111818907B (en) | Film for bio-attachment | |
| JP7170233B2 (en) | Adhesive film for biological application, sheet for application to biological application, and cosmetic method for attaching film for biological application | |
| JP2015110537A (en) | Sticking sheet and production method of the same | |
| JP7170232B2 (en) | Adhesive film for living body and cosmetic method of sticking the film for living body | |
| JP2023175357A (en) | Thin film laminate | |
| JP2015232086A (en) | Sheet for sticking | |
| JP2015144641A (en) | Sheet for sticking |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 19802945 Country of ref document: EP Kind code of ref document: A1 |
|
| DPE1 | Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101) | ||
| ENP | Entry into the national phase |
Ref document number: 2020518970 Country of ref document: JP Kind code of ref document: A |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 19802945 Country of ref document: EP Kind code of ref document: A1 |